{
  "meta": {
    "title": "00020_Late_Night_Pyq_Pyt_Marathon_-_20",
    "url": "https://brainandscalpel.vercel.app/00020-late-night-pyq-pyt-marathon-20-e3b77c5a.html",
    "scrapedAt": "2025-11-29T17:24:34.715Z"
  },
  "questions": [
    {
      "id": 6855,
      "choices": [
        {
          "id": 27388,
          "text": "<p><span style=\"font-size:12.0pt;\">Closure of aortic and pulmonary valves</span></p>"
        },
        {
          "id": 27389,
          "text": "<p><span style=\"font-size:12.0pt;\">Vibrations in the ventricular wall during systole</span></p>"
        },
        {
          "id": 27390,
          "text": "<p><span style=\"font-size:12.0pt;\">Ventricular filling</span></p>"
        },
        {
          "id": 27391,
          "text": "<p><span style=\"font-size:12.0pt;\">Closure of mitral and tricuspid valves</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The fourth heart sound is caused by: (</span>AIIMS Nov 2017)</p>",
      "unique_key": "Q8776094",
      "question_audio": null,
      "question_video": null,
      "map_id": 12374086,
      "difficulty_level": "intermediate",
      "subjects_id": [
        2
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Ventricular filling</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The fourth heart sound is caused by ventricular filling.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Atrial Heart Sound (Fourth Heart Sound)</strong> – Occurs when the atria contract, and presumably, it is caused by the inrush of blood into the ventricles, which initiates vibrations similar to those of the third heart sound.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other heart sounds:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>First heart sound</strong> – contraction of the ventricles first causes sudden backflow of blood against the A-V valves (the tricuspid and mitral valves) causing them to close producing the first heart sound.</span></li><li><span style=\"font-size:12.0pt;\"><strong>The second heart sound</strong> results from sudden closure of the semilunar valves at the end of systole.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Third Heart Sound</strong> – occasionally a weak, rumbling third heart sound is heard at the beginning of the middle third of diastole. Most probably it is due to oscillation of blood back and forth between the walls of the ventricles initiated by inrushing blood from the atria.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The fourth heart sound (S4) is caused by the atrial contraction and the subsequent inrush of blood into the ventricles, which initiates vibrations similar to those of the third heart sound.</span></p>",
      "correct_choice_id": 27390,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19958,
      "choices": [
        {
          "id": 79793,
          "text": "<p><span style=\"font-size:12.0pt;\">Surface tension - decreased; Compliance - increased</span></p>"
        },
        {
          "id": 79794,
          "text": "<p><span style=\"font-size:12.0pt;\">Surface tension - increased; Compliance - decreased</span></p>"
        },
        {
          "id": 79795,
          "text": "<p><span style=\"font-size:12.0pt;\">Both surface tension and compliance decreased</span></p>"
        },
        {
          "id": 79796,
          "text": "<p><span style=\"font-size:12.0pt;\">Both surface tension and compliance increased</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A preterm baby who was delivered at 28 weeks developed respiratory distress syndrome. Which of the following is true about surface tension and compliance in this baby?(NEET PG 2023)</span></p>",
      "unique_key": "Q6410234",
      "question_audio": null,
      "question_video": null,
      "map_id": 12374087,
      "difficulty_level": "beginner",
      "subjects_id": [
        2
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B. Surface tension - increased; Compliance - decreased</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This preterm baby who developed respiratory distress syndrome has surfactant deficiency. Due to which surface tension increases and compliance decreases.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Surfactant (Lecithin/Dipalmitoyl phosphatidyl Choline) is produced by specialized cells called type II alveolar cells in the lungs. Surfactant molecules have a hydrophilic (water-attracting) head and a hydrophobic (water-repellent) tail. This unique structure allows surfactant to lower the surface tension at the air-liquid interface of the alveoli. It reduces the attractive forces between water molecules, preventing the alveoli from collapsing during expiration.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Compliance refers to the ability of the lungs to expand and recoil efficiently during breathing. Without surfactant, the surface tension within the alveoli would be high, making it difficult for the lungs to inflate during inspiration and causing them to collapse more readily during expiration.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective</strong>:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In preterm infants, especially those born before the lungs have matured at around 28 weeks, the lack of adequate surfactant leads to increased surface tension and decreased compliance, contributing to the development of respiratory distress syndrome.</span></p>",
      "correct_choice_id": 79794,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54789,
      "choices": [
        {
          "id": 218621,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">A - Cortisol B - Aldosterone C - Androgens D - Epinephrine</span></span></span></p>"
        },
        {
          "id": 218622,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">A - Aldosterone B - Cortisol C - Androgens D - Epinephrine</span></span></span></p>"
        },
        {
          "id": 218623,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">A - Epinephrine B - Cortisol C - Aldosterone D - Androgens</span></span></span></p>"
        },
        {
          "id": 218624,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">A - Aldosterone B - Epinephrine C - Androgens D - Cortisol</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which hormones are produced from these zones?&nbsp;</span></span><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">(INICET MAY 2024)</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/26/whatsapp-image-2024-08-26-at-20639-pm.jpeg\" style=\"height:511px; width:400px\" /></p>",
      "unique_key": "Q2253990",
      "question_audio": null,
      "question_video": null,
      "map_id": 12374088,
      "difficulty_level": "beginner",
      "subjects_id": [
        2
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Ans. B) A - Aldosterone B - Cortisol C - Androgens D - Epinephrine</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The adrenal gland, located on top of the kidneys, consists of the adrenal cortex and the adrenal medulla. The cortex is further divided into three zones: the zona glomerulosa, zona fasciculata, and zona reticularis. These zones are responsible for producing different types of hormones, remembered by the <strong>mnemonic &quot;GFR.&quot;</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Zona Glomerulosa (A):</span></strong><span style=\"font-size:12.0pt\"> This outermost layer is responsible for producing mineralocorticoids, the most important being <strong>Aldosterone</strong>. Aldosterone plays a critical role in regulating sodium and potassium balance in the body.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Zona Fasciculata (B):</span></strong><span style=\"font-size:12.0pt\"> The middle layer produces glucocorticoids, primarily <strong>Cortisol</strong>. Cortisol is involved in stress response, metabolism regulation, and immune function.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Zona Reticularis (C):</span></strong><span style=\"font-size:12.0pt\"> The innermost cortical layer produces androgens, specifically <strong>DHEA (Dehydroepiandrosterone)</strong>, which is a precursor to sex steroids like testosterone and estrogen.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Adrenal Medulla (D):</span></strong><span style=\"font-size:12.0pt\"> The medulla produces catecholamines, primarily <strong>Epinephrine (adrenaline)</strong>, which is crucial for the fight-or-flight response.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The adrenal cortex is divided into three zones&mdash;zona glomerulosa, zona fasciculata, and zona reticularis&mdash;which produce aldosterone, cortisol, and androgens, respectively. The adrenal medulla produces catecholamines, primarily epinephrine</span></span></span></p>",
      "correct_choice_id": 218622,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6731,
      "choices": [
        {
          "id": 26893,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Decrease in GFR</span></span></span></p>"
        },
        {
          "id": 26894,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Decreases renal blood flow</span></span></p>"
        },
        {
          "id": 26895,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Decreases oncotic pressure in glomerular capillaries</span></span></span></p>"
        },
        {
          "id": 26896,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Increases hydrostatic pressure in glomerular capillaries</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Efferent arteriolar constriction causes all except? (</span></span>AIIMS May 2017)</p>",
      "unique_key": "Q3144481",
      "question_audio": null,
      "question_video": null,
      "map_id": 12374089,
      "difficulty_level": "intermediate",
      "subjects_id": [
        2
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C) Decreases oncotic pressure in glomerular capillaries</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation </span></span></strong></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/28/screenshot-2024-05-28-180328.png\" style=\"height:265px; width:400px\" /></span></span></strong></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Efferent arteriolar constriction <strong>increases</strong> oncotic pressure in glomerular capillaries.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Constriction of the efferent arterioles:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Increases the resistance to outflow from the glomerular capillaries raising the glomerular hydrostatic pressure</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Reduces renal blood flow</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Increase in filtration fraction and glomerular colloid osmotic pressure (oncotic pressure) </span></span></span></li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Therefore, if the constriction of efferent arterioles is severe (more than about a threefold increase in efferent arteriolar resistance), the rise in colloid osmotic pressure (oncotic pressure) exceeds the increase in glomerular capillary hydrostatic pressure caused by efferent arteriolar constriction. When this occurs, the net force for filtration actually decreases, causing a reduction in GFR.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Decrease in GFR:&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Incorrect in this context as initial efferent arteriolar constriction might actually increase GFR by raising hydrostatic pressure, though severe constriction can eventually decrease it.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. Decreases renal blood flow:&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Incorrect as this is a direct effect of efferent arteriolar constriction.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Increases hydrostatic pressure in glomerular capillaries:&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Incorrect as this is indeed a result of efferent arteriolar constriction.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Efferent arteriolar constriction leads to an increase in both hydrostatic and oncotic pressures within the glomerular capillaries, which can modify renal blood flow and the dynamics of glomerular filtration. It does not decrease the oncotic pressure in the glomerular capillaries.</span></span></p>",
      "correct_choice_id": 26895,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11351,
      "choices": [
        {
          "id": 45370,
          "text": "<p><span style=\"font-size:12.0pt;\">STEMI</span></p>"
        },
        {
          "id": 45371,
          "text": "<p><span style=\"font-size:12.0pt;\">NSTEMI</span></p>"
        },
        {
          "id": 45372,
          "text": "<p><span style=\"font-size:12.0pt;\">Stable Angina</span></p>"
        },
        {
          "id": 45373,
          "text": "<p><span style=\"font-size:12.0pt;\">Unstable Angina</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 74-year-old man with a history of dyslipidemia, hypertension, and aortic sclerosis presents to the emergency department with chest pain. He took 3 NTG tablets with no relief. His vitals are stable and cardiac enzymes were normal. An ECG on admission is shown. What is the likely diagnosis? (Neet pg 2022)</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/29/screenshot-2024-07-29-191548.jpg\" alt=\"\" width=\"500\" height=\"268\"></p>",
      "unique_key": "Q4369885",
      "question_audio": null,
      "question_video": null,
      "map_id": 12374090,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D. Unstable Angina</strong></span></p><p><span style=\"font-size:11pt;\"><strong>&nbsp;</strong></span></p><p><span style=\"font-size:12.0pt;\">The patient's presentation includes chest pain unrelieved by nitroglycerin (NTG), stable vitals, and normal cardiac enzymes. The provided ECG is normal, showing no signs of ST elevation or ischemic changes such as ST depression or T wave inversion.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Unstable Angina</strong> involves chest pain at rest or with minimal exertion, and normal cardiac enzymes. The patient has multiple risk factors (dyslipidemia, hypertension, aortic sclerosis), and the fact that his chest pain did not respond to NTG and his enzymes are normal strongly suggests unstable angina.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. STEMI: </strong>STEMI is characterized by ST elevation on ECG and elevated cardiac enzymes indicating myocardial necrosis. This patient's ECG shows no ST elevation, and his cardiac enzymes are normal, making STEMI unlikely.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. NSTEMI: </strong>NSTEMI would present with elevated cardiac enzymes due to myocardial damage, despite the absence of ST elevation. This patient’s normal enzyme levels exclude NSTEMI.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Stable Angina: </strong>Stable angina presents with chest pain that is typically relieved by rest or nitroglycerin. The patient’s chest pain persisted despite taking NTG, indicating that stable angina is not the correct diagnosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Unstable angina is characterized by chest pain that occurs at rest or with minimal exertion, does not respond to nitroglycerin, and is associated with normal cardiac enzyme levels.</span></p>",
      "correct_choice_id": 45373,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "ImageBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 24406,
      "choices": [
        {
          "id": 97585,
          "text": "<p><span style=\"font-size:12.0pt;\">1,2,3,4</span></p>"
        },
        {
          "id": 97586,
          "text": "<p><span style=\"font-size:12.0pt;\">2,3,4,1</span></p>"
        },
        {
          "id": 97587,
          "text": "<p><span style=\"font-size:12.0pt;\">1,3,4,2</span></p>"
        },
        {
          "id": 97588,
          "text": "<p><span style=\"font-size:12.0pt;\">1,4,2,3</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Organize the listed bands within the sarcomere, starting from the periphery and moving towards the center.&nbsp;</span>(INICET MAY 2023)</p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\">&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">Z line</span></li><li><span style=\"font-size:12.0pt;\">M line</span></li><li><span style=\"font-size:12.0pt;\">A band</span></li><li><span style=\"font-size:12.0pt;\">H zone&nbsp;</span>&nbsp;</li></ol><p>&nbsp;</p>",
      "unique_key": "Q2728730",
      "question_audio": null,
      "question_video": null,
      "map_id": 12374201,
      "difficulty_level": "beginner",
      "subjects_id": [
        2
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) 1,3,4,2</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The proper order of bands within the sarcomere, moving from the periphery towards the center, is as follows: Z line - I band - A band - H zone - M line.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/08/whatsapp-image-2023-07-04-at-125612.jpg\" alt=\"\" width=\"700\" height=\"318\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Z line</strong>: A dense protein structure that separates one sarcomere from the next and serves as an anchor for actin filaments.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>I band</strong>: The light-colored region in a sarcomere composed of only thin actin filaments.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>A band</strong>: The dark-colored region in a sarcomere containing both thick myosin and thin actin filaments.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>H zone</strong>: The central part of the A band where only thick myosin filaments are present.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>M line</strong>: The center of the sarcomere, providing structural support and anchoring the myosin filaments.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"background-color:white;color:#0d0d0d;font-size:12.0pt;\">The correct order of bands within the sarcomere, from the periphery towards the center, is Z line, A band, H zone, and M line.</span></p>",
      "correct_choice_id": 97587,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6838,
      "choices": [
        {
          "id": 27320,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Primary active transport</span></span></span></p>"
        },
        {
          "id": 27321,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Secondary active transport</span></span></span></p>"
        },
        {
          "id": 27322,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Facilitated diffusion</span></span></span></p>"
        },
        {
          "id": 27323,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Any of the above</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The mechanism by which glucose is absorbed in the intestine is? (</span></span>AIIMS May 2018)</p>",
      "unique_key": "Q1179921",
      "question_audio": null,
      "question_video": null,
      "map_id": 12374202,
      "difficulty_level": "beginner",
      "subjects_id": [
        2
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B) Secondary active transport</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Glucose enters the lumen of the small intestine.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Sodium ions (Na+) are present in the lumen of the intestine.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Sodium-Glucose Co-Transporter 1 (SGLT1) on the luminal membrane of enterocytes facilitates glucose absorption:</span></span></span>\r\n\t<ol style=\"list-style-type:lower-alpha\">\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">SGLT1 binds to both glucose and sodium ions.</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Sodium ions move down their electrochemical gradient into the enterocyte, providing energy for transport.</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Glucose molecules are co-transported with sodium ions into the enterocyte.</span></span></span></li>\r\n\t</ol>\r\n\t</li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Glucose enters the cytoplasm of the enterocyte.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Inside the enterocyte, glucose can be used for energy or transported across the basolateral membrane.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Glucose Transporter 2 (GLUT2) on the basolateral membrane of enterocytes facilitates glucose transport out of the cell:</span></span></span>\r\n\t<ol style=\"list-style-type:lower-alpha\">\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">GLUT2 allows glucose to move down its concentration gradient.</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Glucose diffuses across the basolateral membrane into the bloodstream.</span></span></span></li>\r\n\t</ol>\r\n\t</li>\r\n\t<li><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glucose is carried away by the bloodstream to various tissues and organs for utilization.</span></span></li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/28/screenshot-2024-05-28-152428.png\" style=\"height:425px; width:500px\" /></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Primary active transport:&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Involves direct use of ATP for the movement of substances against their concentration gradient and does not apply to glucose absorption in the intestine.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Facilitated diffusion:&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Passive movement of molecules along their concentration gradient through a membrane protein, applies to the exit of glucose at the basolateral side but not to its uptake at the luminal side.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Any of the above:&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Not applicable as the specific mechanism for glucose absorption is secondary active transport.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Glucose is absorbed in the intestine through secondary active transport utilizing the Sodium-Glucose Co-Transporter 1 (SGLT1), which couples the energetically favorable transport of sodium with the transport of glucose against its gradient into enterocytes.</span></span></span></p>",
      "correct_choice_id": 27321,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 34049,
      "choices": [
        {
          "id": 136031,
          "text": "<p><span style=\"font-size:12.0pt;\">Bronchiectasis</span></p>"
        },
        {
          "id": 136032,
          "text": "<p><span style=\"font-size:12.0pt;\">Sarcoidosis</span></p>"
        },
        {
          "id": 136033,
          "text": "<p><span style=\"font-size:12.0pt;\">Pulmonary fibrosis</span></p>"
        },
        {
          "id": 136034,
          "text": "<p><span style=\"font-size:12.0pt;\">COPD</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">The graph given below shows the normal FEV1 and FVC curves for a normal lung and a diseased lung. The abnormal graph represents which of the following?</span>(INICET NOVEMBER 2023)</p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/29/picture14_AhUMt1O.jpg\" alt=\"\" width=\"300\" height=\"220\"></span></p>",
      "unique_key": "Q2360615",
      "question_audio": null,
      "question_video": null,
      "map_id": 12374223,
      "difficulty_level": "beginner",
      "subjects_id": [
        2
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) COPD</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In the provided spirometry graph, the normal and abnormal curves represent volumes and flow rates during forced expiration.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The abnormal graph is indicative of COPD, as it shows a significant reduction in FEV1 with a less pronounced reduction in FVC, resulting in a decreased FEV1/FVC ratio</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Chronic Obstructive Pulmonary Disease (COPD) is characterized by a decrease in FEV1 with a more preserved FVC, leading to a reduced FEV1/FVC ratio, which is consistent with the abnormal curve in the graph.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Bronchiectasis:</strong> This condition where the walls of airways (bronchi) widen and are thickened from inflammation. It can cause obstructive lung changes, but the FEV1/FVC ratio is often normal or less dramatically reduced than in COPD. The spirometry curve will not show the same pattern as shown in graph.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Sarcoidosis:</strong> This is a restrictive lung disease, typically showing a reduction in both FEV1 and FVC but with a normal or increased FEV1/FVC ratio, unlike the pattern shown for the diseased lung in the graph.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Pulmonary fibrosis:</strong> As a restrictive disease, pulmonary fibrosis would typically show a decrease in lung volumes (including FVC) with a normal or increased FEV1/FVC ratio, which differs from the obstructive pattern shown.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The spirometry pattern for COPD shows a significant reduction in FEV1 with a less pronounced reduction in FVC, leading to a decreased FEV1/FVC ratio. This is indicative of obstructive lung disease.</span></p>",
      "correct_choice_id": 136034,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6743,
      "choices": [
        {
          "id": 26941,
          "text": "<p><span style=\"font-size:12.0pt;\">0.8</span></p>"
        },
        {
          "id": 26942,
          "text": "<p><span style=\"font-size:12.0pt;\">1</span></p>"
        },
        {
          "id": 26943,
          "text": "<p><span style=\"font-size:12.0pt;\">1.25</span></p>"
        },
        {
          "id": 26944,
          "text": "<p><span style=\"font-size:12.0pt;\">1.5</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Calculate the respiratory quotient (RQ) in a patient with 50kg body weight, if the CO<sub>2 </sub>exhaled is 200ml/min and 0<sub>2</sub><sup> </sup>consumed is 250 ml/min? (</span>INICET May 2020)</p>",
      "unique_key": "Q3517896",
      "question_audio": null,
      "question_video": null,
      "map_id": 12374224,
      "difficulty_level": "beginner",
      "subjects_id": [
        2
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) 0.8</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The respiratory quotient is 0.8.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This ratio of carbon dioxide output to oxygen usage is called the respiratory quotient.&nbsp;In the above problem, the CO<sub>2</sub> production is 200mL/min, while the 0<sub>2</sub> consumption is 250mL/min.</span></p><p><br><span style=\"font-size:12.0pt;\">So, Respiratory quotient = 200/250 = 0.8</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The respiratory quotient (RQ) is used for determining the metabolic utilization of various foods.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">RQ of carbohydrates is 1</span></li><li><span style=\"font-size:12.0pt;\">RQ of fats is 0.70.</span></li><li><span style=\"font-size:12.0pt;\">RQ of proteins is 0.80.</span></li></ul>",
      "correct_choice_id": 26941,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8782,
      "choices": [
        {
          "id": 35095,
          "text": "<p><span style=\"font-size:12.0pt;\">J reflex</span></p>"
        },
        {
          "id": 35096,
          "text": "<p><span style=\"font-size:12.0pt;\">Cushing reflex</span></p>"
        },
        {
          "id": 35097,
          "text": "<p><span style=\"font-size:12.0pt;\">Bezold jarisch reflex</span></p>"
        },
        {
          "id": 35098,
          "text": "<p><span style=\"font-size:12.0pt;\">Bainbridge reflex</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which Reflex is responsible for tachycardia during right atrial distension?&nbsp;(NEET PG 2019)</span></p>",
      "unique_key": "Q1707429",
      "question_audio": null,
      "question_video": null,
      "map_id": 12374225,
      "difficulty_level": "beginner",
      "subjects_id": [
        2
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D. Bainbridge reflex</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Bainbridge reflex is a cardioaccelerator reflex that increases the heart rate when venous return is increased. Since this reflex arises from right atrium, it is also called right atrial reflex.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/27/whatsapp-image-2023-06-12-at-1901242.jpg\" alt=\"\" width=\"673\" height=\"770\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;A. J Reflex</strong>: Apnea followed by rapid breathing, bradycardia, and hypotension due to J receptor (C-receptor, juxta-pulmonary capillary receptor) stimulation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;B. Cushing Reflex</strong>: Incorrect because the Cushing reflex involves increased blood pressure, bradycardia, and respiratory depression in response to increased intracranial pressure, not right atrial distension.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;C.</strong> <strong>Bezold-Jarisch Reflex</strong>: Bezold-Jarisch reflex is the reflex characterized by bradycardia and hypotension, caused by stimulation of chemoreceptors present in the wall of left ventricles by substances such as alkaloids. It is also called coronary chemoreflex. Vagal fibers form the afferent and efferent pathways of this reflex.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The Bainbridge reflex is responsible for inducing tachycardia in response to right atrial distension. It serves to adjust heart rate upward when venous return to the heart increases, ensuring optimal cardiac output and circulation efficiency.</span></p>",
      "correct_choice_id": 35098,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6774,
      "choices": [
        {
          "id": 27065,
          "text": "<p><span style=\"font-size:12.0pt;\">Active Na+ reabsorption, passive CI- reabsorption, passive K+ secretion, active secretion of HCO3-</span></p>"
        },
        {
          "id": 27066,
          "text": "<p><span style=\"font-size:12.0pt;\">Passive Na+ reabsorption, active CI- reabsorption, passive K+ secretion, active secretion of HCO3-</span></p>"
        },
        {
          "id": 27067,
          "text": "<p><span style=\"font-size:12.0pt;\">Passive Na+ secretion, active CI- reabsorption, active K+ secretion, passive secretion of HCO3-</span></p>"
        },
        {
          "id": 27068,
          "text": "<p><span style=\"font-size:12.0pt;\">Active Na+ reabsorption, passive CI- reabsorption, active K+ secretion, passive secretion of HCO3-</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The second phase of saliva secretion involves:&nbsp;</span>(INICET MAY 2022)</p>",
      "unique_key": "Q9428008",
      "question_audio": null,
      "question_video": null,
      "map_id": 12374226,
      "difficulty_level": "difficult",
      "subjects_id": [
        2
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Active Na+ reabsorption, passive CI- reabsorption, active K+ secretion, passive secretion of HCO3-</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">First, sodium ions are actively reabsorbed from all the salivary ducts and potassium ions are actively secreted in exchange for the sodium. Excess sodium reabsorption over potassium secretion, creates electrical negativity of about -70 millivolts in the salivary ducts; this in turn causes chloride ions to be reabsorbed passively. Therefore, the chloride ion concentration in the salivary fluid falls to a very low level, matching the ductal decrease in sodium ion concentration.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Active Na+ reabsorption</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">(The ductal cells actively transport sodium ions (Na+) from the saliva into the interstitial fluid surrounding the ducts. This reabsorption of sodium ions helps in concentrating the saliva).&nbsp;Conc.&nbsp; 15 mEq/L</span></p><p><span style=\"font-size:12.0pt;\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ↓</span></p><p><span style=\"font-size:12.0pt;\"><strong>Passive Cl- reabsorption</strong></span></p><p><span style=\"font-size:12.0pt;\">(As sodium ions are reabsorbed, chloride ions (Cl-) passively follow along due to electrical charge balance. This results in the reabsorption of chloride ions from the saliva into the interstitial fluid). Conc.&nbsp; 15 mEq/L</span></p><p><span style=\"font-size:12.0pt;\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ↓</span></p><p><span style=\"font-size:12.0pt;\"><strong>Active K+ secretion</strong></span></p><p><span style=\"font-size:12.0pt;\">(The ductal cells actively secrete potassium ions (K+) into the saliva. This secretion helps in maintaining the concentration of potassium ions within the saliva). Conc.&nbsp; 30 mEq/L</span></p><p><span style=\"font-size:12.0pt;\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ↓</span></p><p><span style=\"font-size:12.0pt;\"><strong>Passive secretion of HCO3-</strong></span></p><p><span style=\"font-size:12.0pt;\">(Hydrogen carbonate ions (HCO3-) are passively secreted from the ductal cells into the saliva. This helps in maintaining the alkaline nature of saliva, which aids in buffering acidic substances and maintaining oral pH). Conc. 50 to 70 mEq/L,</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/30/screenshot-2024-05-30-115047.png\" alt=\"\" width=\"600\" height=\"446\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Active Na+ reabsorption, passive Cl- reabsorption, passive K+ secretion, active secretion of HCO3-:&nbsp;</strong>Incorrect. While Na+ and Cl- processes are correct, K+ secretion is active, not passive.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Passive Na+ reabsorption, active Cl- reabsorption, passive K+ secretion, active secretion of HCO3-:&nbsp;</strong>Incorrect. Na+ reabsorption and Cl- reabsorption roles are reversed, and K+ secretion is active.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Passive Na+ secretion, active Cl- reabsorption, active K+ secretion, passive secretion of HCO3-:&nbsp;</strong>Incorrect. Na+ reabsorption should be active, not passive.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The second phase of saliva secretion involves active Na+ reabsorption, passive Cl- reabsorption, active K+ secretion, and passive secretion of HCO3-, crucial for maintaining electrolyte balance and pH in saliva.</span></p>",
      "correct_choice_id": 27068,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6869,
      "choices": [
        {
          "id": 27444,
          "text": "<p><span style=\"font-size:12.0pt;\">Central capillary dilatation → Wheal → Surrounding flare.</span></p>"
        },
        {
          "id": 27445,
          "text": "<p><span style=\"font-size:12.0pt;\">Central capillary dilatation → Wheal without surrounding flare.</span></p>"
        },
        {
          "id": 27446,
          "text": "<p><span style=\"font-size:12.0pt;\">Central capillary dilatation → Wheal with exaggerated surrounding flare.</span></p>"
        },
        {
          "id": 27447,
          "text": "<p><span style=\"font-size:12.0pt;\">Absent Triple Response</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">On performing a Histamine test on an individual with brachial plexus trunk injury, you can expect? (</span>AIIMS Nov 2018)</p>",
      "unique_key": "Q2933287",
      "question_audio": null,
      "question_video": null,
      "map_id": 12374227,
      "difficulty_level": "intermediate",
      "subjects_id": [
        2
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Central capillary dilatation → Wheal without surrounding flare</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In patient with brachial plexus trunk injury, there is anesthesia over the skin in that region. Histamine test in this patient will result in capillary dilatation and wheal without surrounding flare.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Intradermal injection of histamine usually causes a triple response in the surrounding skin which includes a red reaction, flare and wheal.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Red reaction is because of capillary dilatation and is independent of innervation.</span></li><li><span style=\"font-size:12.0pt;\">Flare reaction is due to dilatation of arterioles caused by the axon reflex.</span></li><li><span style=\"font-size:12.0pt;\">Axon reflex or antidromic reflex is the process by which the impulses are conducted in a direction opposite to the normal direction. Normally, the impulses produced by a cutaneous pain receptor pass through sensory nerve fiber towards the nerve cell body in posterior nerve root ganglion. Some of these impulses pass through the other branches of the same fiber in the opposite direction and reach the blood vessels supplied by these branches. Impulses now dilate the blood vessels. This is called the antidromic or axon reflex. Thus, flare is absent in anesthetized skin.</span></li><li><span style=\"font-size:12.0pt;\">Wheal (skin edema) is due to increased capillary permeability</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The triple response can be seen after total sympathectomy</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The incomplete triple response over the anesthetic skin is characteristic of postganglionic lesions.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In a patient with a brachial plexus trunk injury, the histamine test will result in central capillary dilatation and a wheal without the surrounding flare due to the disruption of the axon reflex.</span></p>",
      "correct_choice_id": 27445,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6957,
      "choices": [
        {
          "id": 27796,
          "text": "<p><span style=\"font-size:12.0pt;\">Transferrin</span></p>"
        },
        {
          "id": 27797,
          "text": "<p><span style=\"font-size:12.0pt;\">Ferroportin</span></p>"
        },
        {
          "id": 27798,
          "text": "<p><span style=\"font-size:12.0pt;\">Hepcidin</span></p>"
        },
        {
          "id": 27799,
          "text": "<p><span style=\"font-size:12.0pt;\">Divalent metal transporter - 1</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Transport of iron into enterocytes is done by which of the following proteins: (</span>INICET Nov 2022)</p>",
      "unique_key": "Q7148408",
      "question_audio": null,
      "question_video": null,
      "map_id": 12374228,
      "difficulty_level": "beginner",
      "subjects_id": [
        2
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Divalent metal transporter – 1</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Transport of iron into enterocytes is done by divalent metal transporter-1 protein.</span></p><p><span style=\"font-size:12.0pt;\">Iron absorption occurs in the duodenum. Iron is reduced to Fe2+ (ferrous) iron by ferrireductases and then transported across the apical membrane by divalent metal transporter 1 (DMT1).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/05/1_8K6VXRG.jpg\" alt=\"\" width=\"700\" height=\"406\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Transferrin</strong>: This protein binds iron in the bloodstream and transports it to various tissues, but it is not involved in the transport of iron into enterocytes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Ferroportin</strong>: This protein exports iron from enterocytes into the bloodstream but does not transport iron into the cells.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Hepcidin</strong>: This hormone regulates iron egress from enterocytes by inhibiting ferroportin but is not involved in the transport of iron into enterocytes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The primary transporter responsible for iron uptake into enterocytes from the intestinal lumen is the divalent metal transporter-1 (DMT1).</span></p>",
      "correct_choice_id": 27799,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10135,
      "choices": [
        {
          "id": 40506,
          "text": "<p><span style=\"font-size:12.0pt;\">Umbilical Vein</span></p>"
        },
        {
          "id": 40507,
          "text": "<p><span style=\"font-size:12.0pt;\">Umbilical artery</span></p>"
        },
        {
          "id": 40508,
          "text": "<p><span style=\"font-size:12.0pt;\">Descending aorta</span></p>"
        },
        {
          "id": 40509,
          "text": "<p><span style=\"font-size:12.0pt;\">Pulmonary Artery</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">In fetal circulation, which vessel carries deoxygenated blood back to the placenta? (NEET PG 2021)</span></p>",
      "unique_key": "Q1118233",
      "question_audio": null,
      "question_video": null,
      "map_id": 12374229,
      "difficulty_level": "beginner",
      "subjects_id": [
        13
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Umbilical artery</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The umbilical arteries are responsible for transporting deoxygenated blood from the fetal heart to the placenta during gestation. In general, arteries carry oxygenated blood away from the heart, but the pulmonary and umbilical arteries are unique in that they carry deoxygenated blood.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/17/untitled-454.jpg\" alt=\"\" width=\"500\" height=\"576\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Clinical significance:</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">The medial umbilical ligament is the remnant of the umbilical artery. The umbilical artery has the following fate:</span><ul><li><span style=\"font-size:12.0pt;\">Proximal parts persist as the superior vesical arteries</span></li><li><span style=\"font-size:12.0pt;\">Distal parts get obliterated and form the medial umbilical ligaments</span></li></ul></li><li><span style=\"font-size:12.0pt;\">The normal umbilical cord contains 2 arteries and 1 vein. A single umbilical artery is the most common cord abnormality. The incidence is higher in twin deliveries. Thus, identifying this during the head-to-toe examination of the newborn becomes extremely important. Congenital anomalies are seen in 30% of cases with a single umbilical artery, trisomy 18 is a common association.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Umbilical Vein</strong>: The umbilical vein carries oxygenated blood from the placenta to the fetus.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Descending Aorta</strong>: In fetal circulation, the descending aorta distributes oxygenated blood from the heart to the lower parts of the body and is not specifically involved in the transport of deoxygenated blood to the placenta.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Pulmonary Artery</strong>: The pulmonary artery carries deoxygenated blood from the right ventricle to the lungs in postnatal circulation but does not play a role in fetal circulation in terms of transport to the placenta.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In fetal circulation, the umbilical arteries carry deoxygenated blood from the fetus to the placenta.</span></p>",
      "correct_choice_id": 40507,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6765,
      "choices": [
        {
          "id": 27029,
          "text": "<p><span style=\"font-size:12.0pt;\">3-6 Hours</span></p>"
        },
        {
          "id": 27030,
          "text": "<p><span style=\"font-size:12.0pt;\">12-18 hours</span></p>"
        },
        {
          "id": 27031,
          "text": "<p><span style=\"font-size:12.0pt;\">30-300 seconds</span></p>"
        },
        {
          "id": 27032,
          "text": "<p><span style=\"font-size:12.0pt;\">3-4 seconds</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What is the duration of short-term memory? (</span>INICET May 2021)</p>",
      "unique_key": "Q8571296",
      "question_audio": null,
      "question_video": null,
      "map_id": 12374230,
      "difficulty_level": "intermediate",
      "subjects_id": [
        2
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) 30-300 seconds</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Short-term memory lasts for seconds to minutes, hence of the given 4 options, 30-300 seconds is the most appropriate answer.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Common classification of memories that divides memories into</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">Short-term memory, which includes memories that last for seconds or at most minutes unless they are converted into longer-term memories&nbsp;</span></li><li><span style=\"font-size:12.0pt;\">Intermediate long-term memories, which last for days to weeks but then fade away</span></li><li><span style=\"font-size:12.0pt;\">Long-term memory, which, once stored, can be recalled up to years or even a lifetime later.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">“working memory,” that includes mainly short-term memory that is used during the course of intellectual reasoning but is terminated as each stage of the problem is resolved.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective :</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Short-term memory lasts for seconds to minutes, storing information temporarily before it is either forgotten or encoded into long-term memory.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Additional Information&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Memories are frequently classified according to the type of information that is stored.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">1. Declarative memory basically means memory of the various details of an integrated thought, such as memory of an important experience that includes –&nbsp;</span></p><ol><li><span style=\"font-size:12.0pt;\">Memory of the surroundings,&nbsp;</span></li><li><span style=\"font-size:12.0pt;\">Memory of time relationships,&nbsp;</span></li><li><span style=\"font-size:12.0pt;\">Memory of causes of the experience,&nbsp;</span></li><li><span style=\"font-size:12.0pt;\">Memory of the meaning of the experience, and&nbsp;</span></li><li><span style=\"font-size:12.0pt;\">Memory of one’s deductions that were left in the person’s mind.</span><br>&nbsp;</li></ol><p><span style=\"font-size:12.0pt;\">2. Skill memory is frequently associated with motor activities of the person’s body, such as all the skills developed for hitting a tennis ball, including automatic memories to&nbsp;</span></p><ol><li><span style=\"font-size:12.0pt;\">Sight the ball,&nbsp;</span></li><li><span style=\"font-size:12.0pt;\">Calculate the relationship and speed of the ball to the racquet, and&nbsp;</span></li><li><span style=\"font-size:12.0pt;\">Deduce rapidly the motions of the body, the arms, and the racquet required to hit the ball as desired.</span></li></ol>",
      "correct_choice_id": 27031,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6735,
      "choices": [
        {
          "id": 26909,
          "text": "<p><span style=\"font-size:12.0pt;\">Temperature Regulation</span></p>"
        },
        {
          "id": 26910,
          "text": "<p><span style=\"font-size:12.0pt;\">Cephalic phase of gastric acid secretion</span></p>"
        },
        {
          "id": 26911,
          "text": "<p><span style=\"font-size:12.0pt;\">Cerebellar motor coordination before movement execution</span></p>"
        },
        {
          "id": 26912,
          "text": "<p><span style=\"font-size:12.0pt;\">Exercise resulting in increased heart rate&nbsp;</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is not an example of feed forward control mechanism? (</span>AIIMS May 2019)</p>",
      "unique_key": "Q4411288",
      "question_audio": null,
      "question_video": null,
      "map_id": 12374231,
      "difficulty_level": "intermediate",
      "subjects_id": [
        2
      ],
      "solution": "<p><strong>Ans. D) Exercise resulting in increased heart rate</strong></p><p>&nbsp;</p><p>Feedforward mechanism is the control system of our body that anticipates and makes corrective changes without any stimulus. Also called as Anticipatory or Adaptive Control.</p><p>&nbsp;</p><p>For instance, some movements of the body occur so rapidly that there is not enough time for nerve signals to travel from the peripheral parts of the body all the way to the brain and then back to the periphery again to control the movement.<br><br>The cerebellum uses feed-forward to predict the sensory consequences of a movement before it is executed. This allows for proactive adjustments and smooth, coordinated movements, especially in learned or repetitive movements. The cerebellum helps in estimating the body's future state, compensating for delays in sensory feedback, calculating prediction errors, and adjusting motor commands accordingly</p><p>&nbsp;</p><p><strong>Examples include</strong></p><p>&nbsp;</p><ul><li>Thermoregulation by hypothalamus BEFORE the changes in environmental temperature changes the body's core body temperature</li><li>Cephalic phase of gastric secretion- Increase in gastric acid secretion on thinking about food</li><li>THINKING about exercise leading to increase heart rate &amp; respiratory rate</li><li>Cerebellar motor coordination before movement execution&nbsp;</li></ul><p>&nbsp;</p><p><strong>Other Options</strong></p><p>&nbsp;</p><p><strong>Option A. Temperature Regulation:</strong>&nbsp;Incorrect. This is a feedforward mechanism where the hypothalamus anticipates and adjusts for temperature changes.</p><p>&nbsp;</p><p><strong>Option B. Cephalic phase of gastric secretion:</strong>&nbsp;Incorrect. This is a feedforward mechanism where thinking about food triggers gastric secretions in anticipation of eating.</p><p>&nbsp;</p><p><strong>Option C. Cerebellar action in motor coordination:</strong>&nbsp;Incorrect. This is a feedforward mechanism where the cerebellum coordinates movements by predicting the required muscle contractions.</p><p>&nbsp;</p><p><strong>Educational Objective</strong></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/29/screenshot-2024-05-29-102015.png\" alt=\"\" width=\"700\" height=\"596\"></strong></span></p>",
      "correct_choice_id": 26912,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6928,
      "choices": [
        {
          "id": 27680,
          "text": "<p><span style=\"font-size:12.0pt;\">Radiation</span></p>"
        },
        {
          "id": 27681,
          "text": "<p><span style=\"font-size:12.0pt;\">Conduction</span></p>"
        },
        {
          "id": 27682,
          "text": "<p><span style=\"font-size:12.0pt;\">Convection</span></p>"
        },
        {
          "id": 27683,
          "text": "<p><span style=\"font-size:12.0pt;\">Sweating</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">An individual is in an environment of a temperature of 47°C. What is the mechanism of heat loss? (</span>INICET Nov 2021)</p>",
      "unique_key": "Q5620301",
      "question_audio": null,
      "question_video": null,
      "map_id": 12374232,
      "difficulty_level": "beginner",
      "subjects_id": [
        2
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Sweating</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The mechanism of heat loss in the given case is sweating.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">As long as skin temperature is greater than the temperature of the surroundings, heat can be lost by radiation and conduction. But when the temperature of the surroundings becomes greater than that of the skin, instead of losing heat, the body gains heat by both radiation and conduction. Under these conditions, the only means by which the body can rid itself of heat is by evaporation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/05/physiology-nov-1-5.jpg\" alt=\"\" width=\"700\" height=\"534\"></span></p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p><span style=\"font-size:11pt;\"><strong>&nbsp;</strong></span></p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Radiation&nbsp;and</strong> <strong>B. Conduction</strong> are effective when the ambient temperature is lower than the body's skin temperature. However, at temperatures higher than the skin temperature, these methods can result in heat gain rather than heat loss.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Convection</strong> can aid in heat loss if the air movement can cool the skin, but at high environmental temperatures, its effectiveness is limited.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">At high environmental temperatures, the body relies primarily on sweating and evaporation to lose heat and regulate body temperature effectively.</span></p>",
      "correct_choice_id": 27683,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 57178,
      "choices": [
        {
          "id": 228101,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Glycolysis </span></span></span></p>"
        },
        {
          "id": 228102,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Glycogenolysis </span></span></span></p>"
        },
        {
          "id": 228103,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">TCA cycle </span></span></span></p>"
        },
        {
          "id": 228104,
          "text": "<p><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Phosphocreatine</span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following provides a rapid source of energy for the resynthesis of ATP in exercising muscles? (AIIMS NOV 2016)</span></span></p>",
      "unique_key": "Q4186795",
      "question_audio": null,
      "question_video": null,
      "map_id": 12374313,
      "difficulty_level": "intermediate",
      "subjects_id": [
        2
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Answer: D. Phosphocreatine</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Explanation:</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">&nbsp;</span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Phosphocreatine serves as an immediate source of energy for the resynthesis of adenosine triphosphate (ATP) in muscles during high-intensity, short-duration exercises. It does so by donating a phosphate group to adenosine diphosphate (ADP) to quickly regenerate ATP. This reaction is both rapid and occurs directly at the sites of muscular contraction, which makes phosphocreatine an essential component in maintaining energy supply during the initial phases of exercise before other slower metabolic pathways (like glycolysis and oxidative phosphorylation) increase their output.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Other options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Option A (Glycolysis)</span></strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"> is incorrect as glycolysis provides energy at a slower rate compared to phosphocreatine and is typically more involved during moderate-intensity exercises.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Option B (Glycogenolysis)</span></strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"> is incorrect because it refers to the breakdown of glycogen to glucose, which then must be further processed via glycolysis or other pathways to produce ATP, thus not as immediate as phosphocreatine.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Option C (TCA cycle)</span></strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"> is also incorrect as the tricarboxylic acid cycle is part of aerobic metabolism, providing energy much slower and is not the primary source during sudden, high-intensity exercise.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Phosphocreatine rapidly provides energy for ATP resynthesis in exercising muscles, crucial during the initial stages of high-intensity activities.</span></span></span></p>",
      "correct_choice_id": 228104,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6907,
      "choices": [
        {
          "id": 27596,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Phosphate</span></p>"
        },
        {
          "id": 27597,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Bicarbonate in the intracellular compartment</span></p>"
        },
        {
          "id": 27598,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Calcium in the extracellular compartment</span></p>"
        },
        {
          "id": 27599,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Intracellular proteins</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Gibbs-Donnan equilibrium is mainly due to? (</span>INICET Nov 2020)</p>",
      "unique_key": "Q6190173",
      "question_audio": null,
      "question_video": null,
      "map_id": 12374434,
      "difficulty_level": "intermediate",
      "subjects_id": [
        2
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Intracellular proteins</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Gibbs-Donnan equilibrium is mainly due to intracellular proteins.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The Gibbs-Donnan effect describes the unequal distribution of Diffusible charged ions on either side of a semipermeable membrane which occurs in the presence of impermeant charged ions.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A</strong>.&nbsp;<strong>Phosphate:</strong> While phosphate ions are present in both intracellular and extracellular compartments, they are not the primary cause of the Gibbs-Donnan equilibrium. Their concentrations do not significantly contribute to the electrochemical gradient and osmotic balance in the same way as intracellular proteins do.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Bicarbonate in the intracellular compartment:</strong> Bicarbonate ions are crucial for maintaining acid-base balance, but they are not the main factor in establishing the Gibbs-Donnan equilibrium. Their movement across membranes is more related to pH regulation rather than creating an electrochemical gradient due to impermeant ions.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Calcium in the extracellular compartment:</strong> Calcium ions are essential for various cellular functions, including muscle contraction and neurotransmission, but they do not play a primary role in the Gibbs-Donnan equilibrium. Their concentration differences across membranes are tightly regulated by channels and pumps, rather than by the presence of impermeant ions.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>At Gibbs-Donnan equilibrium</strong>,</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">On each side of the membrane, each solution will be electrically neutral</span></li><li><span style=\"font-size:12.0pt;\">The product of diffusible ions on one side of the membrane will be equal to the product of diffusible ions on the other side of the membrane</span></li><li><span style=\"font-size:12.0pt;\">The electrochemical gradients produced by unequal distribution of charged ions produces a transmembrane potential difference which can be calculated using the Nernst equation</span></li><li><span style=\"font-size:12.0pt;\">The presence of impermeant ions on one side of the membrane creates an osmotic diffusion gradient attracting water into that compartment.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Intracellular proteins are negatively charged non-permeable ions, then distribution of other permeable ions is affected in a predictable way (Donnan Effect) so that at equilibrium their concentration ratios are equal.</span></p>",
      "correct_choice_id": 27599,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6886,
      "choices": [
        {
          "id": 27512,
          "text": "<p><span style=\"font-size:12.0pt;\">Downregulation of aquaporin 2 production</span></p>"
        },
        {
          "id": 27513,
          "text": "<p><span style=\"font-size:12.0pt;\">Increase in urine osmolarity</span></p>"
        },
        {
          "id": 27514,
          "text": "<p><span style=\"font-size:12.0pt;\">Decrease in ADH secretion</span></p>"
        },
        {
          "id": 27515,
          "text": "<p><span style=\"font-size:12.0pt;\">Upregulation of aquaporin 2 production</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">\"Vasopressin escape\" in SIADH results due to: (</span>AIIMS Nov 2019)</p>",
      "unique_key": "Q7138174",
      "question_audio": null,
      "question_video": null,
      "map_id": 12374435,
      "difficulty_level": "intermediate",
      "subjects_id": [
        2
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Downregulation of aquaporin 2 production</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Vasopressin escape in SIADH (Syndrome of inappropriate ADH secretion) results due to downregulation of aquaporin 2 production.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Downregulation of aquaporin-2 receptors occurs due to prolonged exposure to elevated vasopressin levels resulting in excessive reabsorption of water, despite high serum ADH levels, thus maintaining euvolemia and preventing excessive dilutional hyponatremia in SIADH. This is called as vasopressin escape.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>B. Increase in urine osmolarity:</strong> Incorrect. Vasopressin escape does not result in an increase in urine osmolarity. Instead, it is characterized by the body's ability to excrete free water to prevent hyponatremia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Decrease in ADH secretion:</strong> Incorrect. Vasopressin escape occurs despite high levels of ADH, not due to a decrease in ADH secretion.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>D. Upregulation of aquaporin 2 production:</strong> Incorrect. The condition involves the downregulation, not upregulation, of aquaporin 2 production.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Syndrome of inappropriate anti-diuretic hormone (SIADH): Pathogenesis and clinical findings</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/29/aiims-physio-nov-2019-02.jpg\" alt=\"\" width=\"900\" height=\"714\"></strong></span></p>",
      "correct_choice_id": 27512,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8803,
      "choices": [
        {
          "id": 35179,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Fibronectin</span></span></span></p>"
        },
        {
          "id": 35180,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Heparan sulfate</span></span></span></p>"
        },
        {
          "id": 35181,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Collagen Type IV</span></span></span></p>"
        },
        {
          "id": 35182,
          "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Entactin</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The protein in the glomerular basement membrane responsible for charge-dependent filtration is?(NEET PG 2020)</span></span></p>",
      "unique_key": "Q8554723",
      "question_audio": null,
      "question_video": null,
      "map_id": 12374436,
      "difficulty_level": "beginner",
      "subjects_id": [
        2
      ],
      "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B. Heparan sulfate </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The glomerular basement membrane (GBM) is an essential component of the glomerular filtration barrier.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The protein in the glomerular basement membrane responsible for charge-dependent filtration is heparan sulfate. As the major determinants of the anionic charge of the GBM, heparan sulfate chains have been thought to impart charge selectivity to the glomerular filtration. It prevents filtration by repelling negatively charged proteins.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Fibronectin</span></strong><span style=\"font-size:12.0pt\">: While fibronectin is involved in cell adhesion and matrix assembly, it does not primarily contribute to the charge-dependent filtration properties of the GBM.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Collagen Type IV</span></strong><span style=\"font-size:12.0pt\">: This type of collagen forms a structural scaffolding in the GBM, providing mechanical strength and stability rather than charge-based selectivity.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Entactin</span></strong><span style=\"font-size:12.0pt\">: Also known as nidogen, entactin helps link the network of laminin and collagen IV in the GBM but does not directly influence charge-based filtration.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Heparan sulfate is the critical component responsible for the charge-dependent filtration in the glomerular basement membrane. Its negative charge effectively repels similarly charged molecules, preventing their passage into the urine, which is essential for the body&#39;s ability to retain vital proteins and other negatively charged substances.</span></span></span></p>",
      "correct_choice_id": 35180,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 57180,
      "choices": [
        {
          "id": 228109,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Synchronized Cardioversion</span></span></span></p>"
        },
        {
          "id": 228110,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Modified Valsalva Maneuver</span></span></span></p>"
        },
        {
          "id": 228111,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Adenosine IV</span></span></span></p>"
        },
        {
          "id": 228112,
          "text": "<p><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Metoprolol IV</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">A 45-year-old man with no significant past medical history presents to the emergency department with sudden onset palpitations, lightheadedness, and shortness of breath. On examination, his heart rate is 180 beats per minute, and his blood pressure is 70/50 mm Hg. ECG shows a narrow QRS complex tachycardia with a regular rhythm consistent with supraventricular tachycardia (SVT). Despite lying flat and receiving IV fluids, his blood pressure remains low. What is the most appropriate next step in the management of this patient?</span></span></span></p>",
      "unique_key": "Q7653302",
      "question_audio": null,
      "question_video": null,
      "map_id": 12374437,
      "difficulty_level": "beginner",
      "subjects_id": [
        2
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Correct Answer: A. Synchronized Cardioversion</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Synchronized cardioversion is the recommended intervention for hemodynamically unstable patients with SVT, as seen in this case where the patient has hypotension and a rapid heart rate. Cardioversion is performed using a defibrillator that synchronizes with the patient&rsquo;s QRS complex, delivering an electrical shock during ventricular depolarization to avoid inducing ventricular fibrillation. This immediate intervention restores normal sinus rhythm and stabilizes the patient&rsquo;s hemodynamic status, making it the first-line treatment in hemodynamically unstable patients with tachyarrhythmias.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Option B. Modified Valsalva Maneuver</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">The modified Valsalva maneuver is a first-line treatment for stable patients with SVT as it increases vagal tone and can terminate the tachycardia. However, it is not appropriate for patients who are hemodynamically unstable, as in this case, where immediate intervention is necessary.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Option C. Adenosine IV</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Adenosine is the drug of choice for stable SVT, acting by transiently blocking atrioventricular nodal conduction and often terminating the arrhythmia. In this unstable patient with hypotension, however, immediate cardioversion is preferred to rapidly stabilize the heart rhythm.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Option D. Metoprolol IV</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Metoprolol, a beta-blocker, can be used to control the rate in various tachyarrhythmias, including SVT. However, its onset is slower, and it is not the treatment of choice in hemodynamically unstable patients where rapid rhythm control is needed.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Synchronized cardioversion is the first-line treatment for hemodynamically unstable patients with narrow or wide complex tachyarrhythmias, including SVT. It provides immediate rhythm control by delivering an electrical shock synchronized with the patient&rsquo;s cardiac cycle, stabilizing the heart rhythm and improving the patient&#39;s clinical condition.</span></span></span></p>",
      "correct_choice_id": 228109,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6971,
      "choices": [
        {
          "id": 27852,
          "text": "<p><span style=\"font-size:12.0pt;\">Residual volume</span></p>"
        },
        {
          "id": 27853,
          "text": "<p><span style=\"font-size:12.0pt;\">Functional residual capacity</span></p>"
        },
        {
          "id": 27854,
          "text": "<p><span style=\"font-size:12.0pt;\">Tidal volume</span></p>"
        },
        {
          "id": 27855,
          "text": "<p><span style=\"font-size:12.0pt;\">Inspiratory reserve volume</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What does the zero pressure indicate in the pressure-volume curve? (</span>INICET Nov 2022)</p>",
      "unique_key": "Q5612252",
      "question_audio": null,
      "question_video": null,
      "map_id": 12374488,
      "difficulty_level": "beginner",
      "subjects_id": [
        2
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Functional residual capacity</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The pressure-volume curve represents the relationship between the lung volumes and the transpulmonary pressures. Zero pressure in this context usually refers to the point where the pressure inside the lungs is equal to the atmospheric pressure, indicating a state of no net airflow. This point corresponds to the functional residual capacity (FRC), which is the volume of air remaining in the lungs after a normal, passive exhalation.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Functional Residual Capacity (FRC):</strong> It is the volume of air present in the lungs at the end of passive expiration. This capacity includes the expiratory reserve volume (ERV) and the residual volume (RV). FRC is an important measure because it represents the balance point between the elastic recoil forces of the lungs and the chest wall.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/05/physiology-5_1-7.jpg\" alt=\"\" width=\"700\" height=\"411\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The functional residual capacity is the volume of the air that remains in the lungs after normal expiration. The normal value is about 2.5 liters.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A:</strong> Residual volume is the air left in the lungs after a maximal expiratory effort.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C:</strong> Tidal volume is the amount of air that moves in during each inspiration or the amount of air that moves out with each expiration, during quiet breathing.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D:</strong> Inspiratory reserve volume is the air inspired with a maximal inspiratory effort in addition to the tidal volume.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The zero pressure in the pressure-volume curve indicates the functional residual capacity, which is the volume of air remaining in the lungs after a normal exhalation.</span></p>",
      "correct_choice_id": 27853,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 475,
      "choices": [
        {
          "id": 1896,
          "text": "<p>A</p>"
        },
        {
          "id": 1897,
          "text": "<p>B</p>"
        },
        {
          "id": 1898,
          "text": "<p>C</p>"
        },
        {
          "id": 1899,
          "text": "<p>D</p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Identify the pelvic diaphragm in the picture given below? (</span>AIIMS Nov 2017)</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/25/inicet-anat-2017-26.jpg\" alt=\"\" width=\"300\" height=\"260\"></span></p>",
      "unique_key": "Q6886485",
      "question_audio": null,
      "question_video": null,
      "map_id": 12374489,
      "difficulty_level": "beginner",
      "subjects_id": [
        3
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A. A</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The structure marked \"A\" is the levator ani muscle which is part of the pelvic diaphragm.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The levator ani is the principal muscle of the pelvic floor and is composed of three parts: the puborectalis, the pubococcygeus, and the iliococcygeus. It is primarily innervated by the pudendal nerve and the S4 nerve root.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/25/inicet-anat-2017-27.jpg\" alt=\"\" width=\"600\" height=\"342\"></span></p><p>&nbsp;</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>The structure marked in the given image are:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>A. Levator ani</strong></span></p><p><span style=\"font-size:12.0pt;\"><strong>B. Sphincter ani externus</strong></span></p><p><span style=\"font-size:12.0pt;\"><strong>C. Obturator muscle</strong></span></p><p><span style=\"font-size:12.0pt;\"><strong>D. Perianal fascia</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Sphincter Ani Externus (External Anal Sphincter)</strong>: This is a circular muscle that surrounds the anus. It's located below the level of the levator ani. It is innervated by the pudendal nerve, allowing for voluntary control over defecation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Obturator Muscle</strong>: This term often refers to two muscles - obturator externus and obturator internus. They are situated on either side of the obturator membrane in the pelvis. <strong>Obturator Externus</strong>: Obturator nerve and <strong>Obturator Internus</strong>: Nerve to obturator internus (a branch of the sacral plexus).</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Perianal Fascia</strong>: The perianal fascia is not a muscle but is the connective tissue located in the perianal region, around the anus. It's part of the deeper layers of the skin in this region. &nbsp;It's associated with various potential spaces that can become sites of abscess formation if there's an infection.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The levator ani muscle is a key component of the pelvic diaphragm, supporting pelvic organs and aiding in fecal continence, illustrating its critical role in both pelvic structure and function.</span></p>",
      "correct_choice_id": 1896,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20835,
      "choices": [
        {
          "id": 83304,
          "text": "<p><span style=\"font-size:12.0pt;\">Plasmodium falciparum</span></p>"
        },
        {
          "id": 83305,
          "text": "<p><span style=\"font-size:12.0pt;\">Plasmodium malariae</span></p>"
        },
        {
          "id": 83306,
          "text": "<p><span style=\"font-size:12.0pt;\">Plasmodium vivax</span></p>"
        },
        {
          "id": 83307,
          "text": "<p><span style=\"font-size:12.0pt;\">Plasmodium ovale</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A boy presented with a fever and chills. Rapid test was positive for specific antigen HRP-2. Which of the following species of Plasmodium is the most likely causative agent? </span>(NEET PG 2023)</p>",
      "unique_key": "Q1060224",
      "question_audio": null,
      "question_video": null,
      "map_id": 12374490,
      "difficulty_level": "beginner",
      "subjects_id": [
        6
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Plasmodium falciparum</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Patient with given clinical symptoms and the HRP-2 positivity points to diagnosis of P. falciparum malaria.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This test is based on the detection of histidine-rich protein-2 (HRP-2), produced only by the asexual forms of Plasmodium falciparum, present on the surface of RBCs. It can detect only Plasmodium falciparum HRP-2 antigen but not the other three species of Plasmodium. Test remains positive until 2 weeks after the cure.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/07/08/picture39.jpg\" alt=\"\" width=\"464\" height=\"150\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Another Kit test is Parasite lactate dehydrogenase (p LDH) which can detect all four Plasmodium species that infect humans.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/07/08/picture40.jpg\" alt=\"\" width=\"602\" height=\"498\"></span></p><p>&nbsp;</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Plasmodium malariae:&nbsp;</strong>Not detected by the HRP-2 test.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Plasmodium vivax&nbsp;</strong>and <strong>Option D. Plasmodium ovale:&nbsp;</strong>Also not detected by the HRP-2 test. They would be identified by other rapid tests targeting different antigens like pLDH (Plasmodium Lactate Dehydrogenase).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">For a rapid diagnosis of Plasmodium falciparum infection, the detection of the HRP-2 antigen is critical. This test is specific to P. falciparum, aiding in rapid treatment decisions crucial for preventing the severe complications associated with this malaria species.</span></p>",
      "correct_choice_id": 83304,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 57181,
      "choices": [
        {
          "id": 228113,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Candidiasis of the esophagus</span></span></span></p>"
        },
        {
          "id": 228114,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Kaposi sarcoma</span></span></span></p>"
        },
        {
          "id": 228115,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Oral candidiasis</span></span></span></p>"
        },
        {
          "id": 228116,
          "text": "<p><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pneumocystis jirovecii pneumonia</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">A 38-year-old man with a history of untreated HIV presents to the clinic with complaints of difficulty swallowing, and a weight loss of 10 pounds over the past two months. His latest CD4 count is 180 cells/&micro;L. The patient is concerned about the progression of his HIV to AIDS. Which of the following is not considered an AIDS-defining illness?</span></span></span></p>",
      "unique_key": "Q2171163",
      "question_audio": null,
      "question_video": null,
      "map_id": 12374651,
      "difficulty_level": "beginner",
      "subjects_id": [
        2
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Correct Answer: C. Oral candidiasis</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Oral candidiasis, commonly known as thrush, is frequently observed in individuals with HIV due to immune suppression but is not considered an AIDS-defining illness. According to the Centers for Disease Control and Prevention (CDC), AIDS-defining conditions are specific infections or cancers that signal the progression of HIV infection to AIDS. Severe forms of candidiasis, such as those affecting the esophagus, bronchi, or lungs, are included in the list of AIDS-defining illnesses, but oral involvement alone does not qualify.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Option A. Candidiasis of the esophagus</span></strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">: This is considered an AIDS-defining illness as it indicates a significant degree of immune compromise, often requiring antifungal treatment and marking the progression of HIV infection to AIDS.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Option B. Kaposi sarcoma</span></strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">: This is an AIDS-defining cancer associated with human herpesvirus 8 (HHV-8). It commonly presents in immunocompromised patients, particularly those with advanced HIV infection.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Option D. Pneumocystis jirovecii pneumonia</span></strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">: This is a common opportunistic infection in AIDS patients, often presenting with severe respiratory symptoms and hypoxia. It is one of the hallmark infections used to define the transition to AIDS.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Oral candidiasis is commonly seen in patients with HIV as a marker of immune suppression but is not considered an AIDS-defining illness. AIDS-defining illnesses include more severe infections and cancers such as esophageal candidiasis, Kaposi sarcoma, and Pneumocystis jirovecii pneumonia, which indicate advanced immunosuppression and progression to AIDS. Understanding these distinctions helps guide clinical decisions and management in HIV-infected patients.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/14/picture2.jpg\" style=\"height:251px; width:700px\" /></span></span></span></p>",
      "correct_choice_id": 228115,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10464,
      "choices": [
        {
          "id": 41822,
          "text": "<p><span style=\"font-size:12.0pt;\">Thick layer of fibrin lining the alveoli</span></p>"
        },
        {
          "id": 41823,
          "text": "<p><span style=\"font-size:12.0pt;\">Acute and chronic alveolar hemorrhage</span></p>"
        },
        {
          "id": 41824,
          "text": "<p><span style=\"font-size:12.0pt;\">Perivascular cuffing</span></p>"
        },
        {
          "id": 41825,
          "text": "<p><span style=\"font-size:12.0pt;\">Pulmonary artery hypertrophy with increased resistance</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 56-year-old man was diagnosed with COVID-19 and was put on mechanical ventilation. He passed away after a week. What is the likely post-mortem change seen in the lungs? (NEET PG 2022)</span></p>",
      "unique_key": "Q6058650",
      "question_audio": null,
      "question_video": null,
      "map_id": 12374652,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Thick layer of fibrin lining the alveoli</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In a patient with severe COVID-19 who was on mechanical ventilation, the likely post-mortem change seen in the lungs is, thick layer of fibrin lining the alveoli.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">COVID-19 is known to cause severe respiratory illness, and in severe cases, patients may require mechanical ventilation. One of the characteristic features of severe COVID-19 pneumonia is the development of acute respiratory distress syndrome (ARDS). ARDS is characterized by diffuse alveolar damage, including the accumulation of fibrin-rich hyaline membranes lining the alveolar walls. This can result in the formation of a thick layer of fibrin lining the alveoli, leading to impaired gas exchange and respiratory failure.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">While acute and chronic alveolar hemorrhage, perivascular cuffing, and pulmonary artery hypertrophy with increased resistance may be seen in other respiratory diseases, they are not typically associated with severe COVID-19 pneumonia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Acute and chronic alveolar hemorrhage</strong>: This may be seen in conditions like vasculitis or certain types of pneumonia but is not a hallmark of severe COVID-19.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Perivascular cuffing</strong>: This refers to lymphocytic infiltration around blood vessels and is more common in viral myocarditis and certain chronic lung diseases.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Pulmonary artery hypertrophy with increased resistance</strong>: This is typically associated with chronic pulmonary hypertension and not an immediate feature of severe COVID-19 pneumonia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In patients with severe COVID-19, especially those who have been on mechanical ventilation, the likely post-mortem finding in the lungs is a thick layer of fibrin lining the alveoli, indicative of acute respiratory distress syndrome (ARDS) and severe diffuse alveolar damage.</span></p>",
      "correct_choice_id": 41822,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 24688,
      "choices": [
        {
          "id": 98713,
          "text": "<p><span style=\"font-size:12.0pt;\">Incorrect antigen</span></p>"
        },
        {
          "id": 98714,
          "text": "<p><span style=\"font-size:12.0pt;\">Incorrect antibody</span></p>"
        },
        {
          "id": 98715,
          "text": "<p><span style=\"font-size:12.0pt;\">Antibody excess</span></p>"
        },
        {
          "id": 98716,
          "text": "<p><span style=\"font-size:12.0pt;\">Antigen excess</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient presented with a prolonged fever of unknown origin (PUO), raising suspicion of brucellosis. To confirm the diagnosis, various dilutions of the patient's serum sample are prepared for a standard agglutination test. The outcome is as follows: No agglutination is observed at serum dilutions of 1:20 and 1:40, while positive agglutination occurs at dilutions of 1:80 and 1:160. What factor is accountable for the lack of agglutination in the initial two dilutions? (INICET MAY 2023)</span></p>",
      "unique_key": "Q6844631",
      "question_audio": null,
      "question_video": null,
      "map_id": 12374653,
      "difficulty_level": "beginner",
      "subjects_id": [
        6
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Antibody excess</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Marrack proposed the lattice hypothesis →</span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">Multivalent antigens combine with Bivalent antibodies</span></li><li><span style=\"font-size:12.0pt;\">Lattice is formed only when antigen and antibodies are in proportion.</span></li><li><span style=\"font-size:12.0pt;\">If&nbsp;antigen or antibodies ,any of them is in excess - there is no lattice formation</span></li><li><span style=\"font-size:12.0pt;\">The absence of a positive test result in the initial two tubes can be attributed to the prozone phenomenon.</span></li><li><span style=\"font-size:12.0pt;\">In this scenario, there is an excess of antibodies in comparison to antigens, which results in a lack of robust or noticeable precipitation.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Zone phenomenon:</strong></span></p><p>&nbsp;</p><ol style=\"list-style-type:lower-alpha;\"><li><span style=\"font-size:12.0pt;\">Prozone = Ab excess = Absent</span></li><li><span style=\"font-size:12.0pt;\">Zone of equivalence = Proper proportion = Peak</span></li><li><span style=\"font-size:12.0pt;\">Post zone = Ag excess = Absent</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/11/whatsapp-image-2023-07-04-at-125643.jpg\" alt=\"\" width=\"700\" height=\"298\"></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/29/screenshot-2024-06-29-150704.png\" alt=\"\" width=\"500\" height=\"316\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Incorrect antigen:</strong> If the antigen were incorrect, there would be no agglutination at any dilution.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Incorrect antibody:</strong> If the antibody were incorrect, there would be no agglutination at any dilution.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Antigen excess:</strong> Antigen excess would cause a postzone phenomenon, not observed here.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The prozone phenomenon, where antibody excess prevents agglutination, can account for the lack of agglutination in low dilution samples.</span></p>",
      "correct_choice_id": 98715,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "INICET",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 48988,
      "choices": [
        {
          "id": 195527,
          "text": "<p><span style=\"font-size:12.0pt;\">Cobalt blue with trypan blue for corneal ulcer</span></p>"
        },
        {
          "id": 195528,
          "text": "<p><span style=\"font-size:12.0pt;\">Cobalt green with Rose Bengal stain for corneal opacity</span></p>"
        },
        {
          "id": 195529,
          "text": "<p><span style=\"font-size:12.0pt;\">Cobalt blue with fluorescein stain for corneal ulcer</span></p>"
        },
        {
          "id": 195530,
          "text": "<p><span style=\"font-size:12.0pt;\">Cobalt blue with lissamine green for corneal abrasion</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following accurately pairs the&nbsp; diagnostic stain with the corneal condition it indicates?</span><span style=\"font-size:11.0pt;\">&nbsp;</span><span style=\"font-size:12.0pt;\">(INICET Nov 2023)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/12/screenshot-2024-06-12-175816.JPG\" alt=\"\" width=\"300\" height=\"224\"></span></p>",
      "unique_key": "Q4709382",
      "question_audio": null,
      "question_video": null,
      "map_id": 12374654,
      "difficulty_level": "beginner",
      "subjects_id": [
        8
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Cobalt blue with fluorescein stain for corneal ulcer</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This is the correct match. Fluorescein, when used with a cobalt blue light, stains areas of corneal epithelial loss, highlighting defects such as corneal ulcers.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Cobalt blue with trypan blue for corneal ulcer</strong>: Trypan blue is generally used in cataract surgery to stain the anterior capsule, not for diagnosing corneal ulcers.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Cobalt green with Rose Bengal stain for corneal opacity</strong>: Rose Bengal stain is actually used to detect damage to the eye's surface cells, particularly in cases of dry eye where these cells are more vulnerable.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Cobalt blue with lissamine green for corneal abrasion</strong>: Lissamine green stains areas of cell loss or damage on the surface of the eye, such as in cases of corneal abrasion or dry eye. It’s used under white light rather than cobalt blue light.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Fluorescein stain under cobalt blue light remains a standard and effective method for diagnosing corneal ulcers due to its ability to vividly highlight areas of epithelial loss.</span></p>",
      "correct_choice_id": 195529,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "ImageBased",
        "INICET",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3491,
      "choices": [
        {
          "id": 13943,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">ELISA</span></span></span></p>"
        },
        {
          "id": 13944,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Western blot</span></span></span></p>"
        },
        {
          "id": 13945,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Real time PCR</span></span></span></p>"
        },
        {
          "id": 13946,
          "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Immunoelectrophoresis</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following method is employed to measure the viral load?</span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:10.5pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> (</span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">INICET MAY 2020)</span></span></p>",
      "unique_key": "Q3866845",
      "question_audio": null,
      "question_video": null,
      "map_id": 12374655,
      "difficulty_level": "beginner",
      "subjects_id": [
        6
      ],
      "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C) Real time PCR </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A real-time polymerase chain reaction (real-time PCR, or qPCR) is a laboratory technique of molecular biology based on the polymerase chain reaction (PCR). It monitors the amplification of a targeted DNA molecule during the PCR (i.e., in real time). Fluorescence is measured after each cycle and the intensity of the fluorescent signal reflects the momentary amount of DNA amplicons in the sample at that specific time. Commonly used for viral load quantification of HIV, hepatitis C virus, hepatitis B virus, and CMV.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>ELISA</strong>: Enzyme-linked immunosorbent assay is primarily used to detect antigens or antibodies in a sample and is not used for measuring viral load.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Western blot</strong>: This technique is used to detect specific proteins in a sample and is not used for measuring viral load.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Immunoelectrophoresis</strong>: This method is used to separate and identify proteins based on their antigen-antibody interactions and is not used for measuring viral load.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Real-time PCR measure viral load</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Western blotting &ndash; detects protein.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">ELISA - detect antigens of infectious agents</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Immuno electrophoresis &ndash; separates antigen following antigen antibody reaction</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 13945,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5209,
      "choices": [
        {
          "id": 20809,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Influenza</span></span></span></p>"
        },
        {
          "id": 20810,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Diphtheria</span></span></span></p>"
        },
        {
          "id": 20811,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Polio</span></span></span></p>"
        },
        {
          "id": 20812,
          "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Typhoid</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vaccine that requires strain change due to evolving organism is: (NEET PG 2019)</span></span></p>",
      "unique_key": "Q1451152",
      "question_audio": null,
      "question_video": null,
      "map_id": 12374656,
      "difficulty_level": "beginner",
      "subjects_id": [
        6
      ],
      "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A) Influenza</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The influenza vaccine is unique among vaccines because it requires periodic updates or strain changes almost every year. This necessity is due to the evolving nature of the influenza virus, particularly the frequent antigenic changes in its surface glycoproteins (hemagglutinin and neuraminidase). These changes can occur through two primary mechanisms:</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Antigenic Drift:</span></strong><span style=\"font-size:12.0pt\"> Minor changes that occur gradually over time as the virus replicates. These small genetic mutations can alter the antigenic properties of the virus, necessitating updates to the vaccine to maintain its effectiveness.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Antigenic Shift:</span></strong><span style=\"font-size:12.0pt\"> Less frequent but more significant changes that can lead to the emergence of a completely new influenza virus subtype. This can potentially lead to pandemics if the new subtype spreads widely and the population has little to no immunity against it.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Diphtheria:</span></strong><span style=\"font-size:12.0pt\"> The vaccine for diphtheria does not require frequent updates or strain changes. The causative bacterium (Corynebacterium diphtheriae) does not exhibit the same level of antigenic variation that necessitates vaccine modification.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Polio:</span></strong><span style=\"font-size:12.0pt\"> Polio vaccines target stable viral antigens of the poliovirus, which do not undergo frequent antigenic changes, thus not requiring periodic strain updates.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Typhoid:</span></strong><span style=\"font-size:12.0pt\"> Typhoid vaccines, such as those for Salmonella Typhi, also do not require frequent changes in formulation, as the bacterial antigens are relatively stable.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The influenza vaccine must be updated regularly to match the antigenically evolving influenza virus strains, primarily due to antigenic drift (gradual) and shift (drastic). This adaptation is essential to enhance vaccine effectiveness and control the spread of flu each season, highlighting the dynamic challenge of influenza virus surveillance and vaccine formulation.</span></span></span></p>",
      "correct_choice_id": 20809,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9913,
      "choices": [
        {
          "id": 39618,
          "text": "<p><span style=\"font-size:12pt;\">Poikiloderma</span></p>"
        },
        {
          "id": 39619,
          "text": "<p><span style=\"font-size:12pt;\">Salt and pepper pigmentation</span></p>"
        },
        {
          "id": 39620,
          "text": "<p><span style=\"font-size:12pt;\">Leukotrichia</span></p>"
        },
        {
          "id": 39621,
          "text": "<p><span style=\"font-size:12pt;\">Vitiligo</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The patient visiting the outpatient department exhibits skin manifestations linked to a disease that includes Raynaud’s phenomenon. What is this skin manifestation shown below? (INICET MAY 2022)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/12/picture6_oxDdSH2.jpg\" alt=\"\" width=\"300\" height=\"225\"></span></p>",
      "unique_key": "Q5559122",
      "question_audio": null,
      "question_video": null,
      "map_id": 12374657,
      "difficulty_level": "beginner",
      "subjects_id": [
        18
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) Salt and pepper pigmentation.</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">The presented clinical scenario indicates <strong>systemic sclerosis</strong>, a complex <strong>autoimmune</strong> condition of uncertain origin with diverse clinical manifestations.</span></li><li><span style=\"font-size:12pt;\">It leads to considerable <strong>disability</strong> and <strong>mortality</strong>, affecting nearly <strong>all organs</strong>.</span></li><li><span style=\"font-size:12pt;\">The defining feature of systemic sclerosis is <strong>scleroderma</strong>, characterized by <strong>thickened</strong> and <strong>indurated</strong> <strong>skin</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Systemic sclerosis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">It also presents with typical skin manifestations of <strong>Raynaud </strong>phenomenon, which include the characteristic <strong>white discoloration </strong>of the <strong>fingers</strong> due to vasospasm and <strong>bluish </strong>discoloration of the fingertips as shown in the image below.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/22/picture3433.jpg\" alt=\"\" width=\"300\" height=\"334\"></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">The skin has a <strong>salt-and-pepper appearance</strong> when there is a loss of pigmentation, which is most noticeable on the <strong>upper back</strong> (as given in the question), chest, and scalp.</span></li><li><span style=\"font-size:12pt;\"><strong>Sclerodactyly</strong> and sclerosis extending proximal to the metacarpophalangeal joints with or without contractures.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/22/picture3566.jpg\" alt=\"\" width=\"300\" height=\"227\"></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Loss of fingertip pulp</span></li><li><span style=\"font-size:12pt;\"><strong>Vasculopathic ulcers</strong> over the bony prominences</span></li><li><span style=\"font-size:12pt;\">Puffy fingers in early disease</span></li><li><span style=\"font-size:12pt;\">Severe flexion <strong>contractures</strong></span></li><li><span style=\"font-size:12pt;\"><strong>Expressionless facies</strong>, mat-like telangiectasias, microstomia, perioral furrowing, and a beak-like nose can be seen as shown in the image below</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/22/picture36.jpg\" alt=\"\" width=\"300\" height=\"199\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A: Poikiloderma is a skin disorder characterized by (ATP)</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Atrophy</strong></span></li><li><span style=\"font-size:12pt;\"><strong>Telangiectasias</strong></span></li><li><span style=\"font-size:12pt;\"><strong>Pigment</strong> abnormalities Hypo and hyper</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/22/picture3733.jpg\" alt=\"\" width=\"250\" height=\"394\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">It is seen in ionizing radiation-damaged skin and <strong>Dermatomyositis</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C:&nbsp;</strong>Sometimes the color of the hair can change to white in the amelanotic lesions of vitiligo. <strong>It is known as leukotrichia</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D:&nbsp;</strong>Sharply demarcated <strong>depigmented macules are a hallmark of vitiligo</strong>. It results from the loss of melanocytes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/22/picture3866.jpg\" alt=\"\" width=\"300\" height=\"211\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>'Salt and Pepper pigmentation'&nbsp;</strong>is a cutaneous manifestation often seen in <strong>systemic</strong> <strong>sclerosis</strong>, a condition which also commonly presents with <strong>Raynaud’s</strong> phenomenon.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref - Rooks textbook of dermatology- 9<sup>th</sup> Edition Chapter 56 page no 56.4</strong></span></p><p><span style=\"font-size:12pt;\"><strong>Harrison’s principles of internal medicine, 21<sup>st</sup> edition 2779</strong></span></p>",
      "correct_choice_id": 39619,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9806,
      "choices": [
        {
          "id": 39191,
          "text": "<p><span style=\"font-size:12.0pt;\">O</span></p>"
        },
        {
          "id": 39192,
          "text": "<p><span style=\"font-size:12.0pt;\">AB</span></p>"
        },
        {
          "id": 39193,
          "text": "<p><span style=\"font-size:12.0pt;\">B</span></p>"
        },
        {
          "id": 39194,
          "text": "<p><span style=\"font-size:12.0pt;\">A</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient has been brought with severe bleeding to your ER. His blood group is unknown. Fresh frozen plasma from which of the following blood groups can be given? (AIIMS NOV 2018)</span></p>",
      "unique_key": "Q2556086",
      "question_audio": null,
      "question_video": null,
      "map_id": 12374658,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) AB</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">FFP from AB blood group can be given to this patient since the universal plasma donor is AB<strong>. AB plasma does not contain antibodies against antigens on RBCs of AB blood group.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Here, the question is about fresh frozen plasma transfusion and not about the packed red cells.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Had the question been about packed RBCs then in case of<strong> emergency packed cell blood transfusion with unknown blood group, O Rh-negative blood</strong> <strong>(universal donor) is transfused.</strong> It is preferred because it lacks the A and B and Rh antigens. Hence, it cannot be hemolyzed by anti-A, anti-B or anti-D antibodies in the recipient's blood.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/06/screenshot-2024-09-06-104002.png\" alt=\"\" width=\"1000\" height=\"917\"></p>",
      "correct_choice_id": 39192,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7495,
      "choices": [
        {
          "id": 29948,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Stop MDT give thalidomide</span></span></span></p>"
        },
        {
          "id": 29949,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Continue MDT, start thalidomide</span></span></p>"
        },
        {
          "id": 29950,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Stop MDT, start systemic corticosteroids</span></span></span></p>"
        },
        {
          "id": 29951,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Continue MDT, start systemic steroids</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In a case where a patient undergoing multi-drug therapy (MDT) experiences a deterioration of existing lesions and nerve complications, what course of action would you consider taking next? (</span></span>NEET PG 2021)</p>",
      "unique_key": "Q7344789",
      "question_audio": null,
      "question_video": null,
      "map_id": 12374659,
      "difficulty_level": "beginner",
      "subjects_id": [
        18
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans.&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">D. Continue MDT, start systemic steroids</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The situation described, where <strong>pre-existing lesions worsen during multi-drug therapy (MDT) for leprosy, indicates a type 1 lepra reaction</strong>. In managing this condition, the recommended approach would be to <strong>continue MDT while initiating systemic steroid treatment.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Type 1 lepra reactions are marked by inflammation of existing skin lesions, <strong>leading to symptoms such as edema, redness, and pain.</strong> While ulcers are uncommon, the development of new lesions is exceptionally rare. Additionally, acute neuritis may occur, presenting with tenderness and impairment of both motor and sensory functions.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In patients with lepra reactions, MDT is never discontinued</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. NSAIDs and oral steroids can be added to treat pain.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Thalidomide</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> is considered the <strong>gold standard</strong> for treating severe cases of type-2 lepra reaction or erythema nodosum leprosum. However, it is <strong>not the Drug of Choice</strong> due to its high cost and potential for adverse drug reactions. <strong>In type II lepra reactions, patients may experience systemic symptoms such as iritis, orchitis, and the appearance of new skin lesions.</strong></span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Type I &amp; II lepra reactions:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/15/screenshot-2024-06-15-113741.png\" style=\"height:311px; width:1000px\" /><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(ENL = Erythema Nodosum Leprosum)</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other options: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Stop MDT give thalidomide</span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Thalidomide is an <strong>immunomodulatory</strong> drug that may be used in certain conditions, like <strong>leprosy</strong> and its complications. </span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">However, <strong>stopping MDT is not recommended</strong> as it is crucial to continue the treatment of the primary disease. Thalidomide is <strong>not used as </strong>treatment for <strong>Type 1 lepra reaction in leprosy</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Continue MDT, start thalidomide &ndash; </span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">While MDT should be continued, thalidomide is not typically used for nerve complications. It&#39;s used <strong>primarily</strong> for severe or recurrent <strong>erythema nodosum leprosum (ENL) Type 2 Lepra reaction,</strong> which is an immune-mediated complication of leprosy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Stop MDT, start systemic corticosteroids</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> &ndash; </span></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Stopping MDT is not advised as the antibiotics in MDT are essential for treating the bacterial infection causing the disease. </span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The MDT should be continued to prevent the development of drug resistance and to adequately treat the underlying infection.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Continue MDT, start systemic steroids</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> - </span></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This is the <strong>correct management</strong> for a leprosy patient with <strong>nerve damage</strong>, which is likely due to an immune reaction called a <strong>leprosy reaction</strong>. <strong>Systemic corticosteroids</strong> are used to control the <strong>inflammation</strong> and prevent further nerve damage. </span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">MDT should be continued to treat the underlying infection.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The reason for selecting option D is that systemic corticosteroids are effective in treating acute nerve inflammation and can prevent further damage while <strong>continuing MDT ensures that the infection is adequately treated.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In the case of <strong>nerve complications </strong>in a patient undergoing <strong>multi-drug therapy </strong>for conditions like <strong>leprosy</strong>, the appropriate course of action is to <strong>continue the anti-microbial therapy</strong> and start <strong>systemic steroids </strong>to manage the <strong>inflammatory</strong> reaction causing nerve damage.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Reference:&nbsp; </span></span><span style=\"font-family:Helvetica\"><strong><span style=\"font-size:9.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Rook&#39;s Textbook of Dermatology -9th Edition Chapter 28 Page no 28.5, 28.12, 28.16</span></span></strong></span></strong></p>",
      "correct_choice_id": 29951,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 2020,
      "choices": [
        {
          "id": 8073,
          "text": "<p><span style=\"font-size:12.0pt;\">Knock out</span></p>"
        },
        {
          "id": 8074,
          "text": "<p><span style=\"font-size:12.0pt;\">Knock down</span></p>"
        },
        {
          "id": 8075,
          "text": "<p><span style=\"font-size:12.0pt;\">Knock in</span></p>"
        },
        {
          "id": 8076,
          "text": "<p><span style=\"font-size:12.0pt;\">Knock up</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">RNAi acts through? (</span>INICET May 2021</p>",
      "unique_key": "Q9534839",
      "question_audio": null,
      "question_video": null,
      "map_id": 12374660,
      "difficulty_level": "beginner",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B)&nbsp;Knock down</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Gene knock down is when function of the gene present is suppressed by inhibiting or degrading the target mRNA so that it cannot form its protein. This is also known as post transcriptional gene silencing or RNA interference (RNAi). This is mediated by micro RNA (miRNA) or small interfering RNA (siRNA) which are small 20-27 nucleotides long non-coding RNAs. miRNA based RNAi involves the uses of three enzymes DROSHA, PASHA and DICER.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;A. Knock out:</strong> This involves removing or taking a gene out, resulting in a complete loss of gene function.</span></p><p style=\"margin-left:24px;\">&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;C. Knock in:</strong> This involves inserting a gene into a specific location within the genome.</span></p><p style=\"margin-left:24px;\">&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;D. Knock up:</strong> This term is not used in the context of gene manipulation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">RNA interference (RNAi) acts through gene knock down by suppressing the function of a gene via degradation or inhibition of its target mRNA, preventing protein formation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><i><strong>Ref- Harper 31<sup>st</sup> e/p 346-348</strong></i></span></p>",
      "correct_choice_id": 8074,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13960,
      "choices": [
        {
          "id": 55801,
          "text": "<p><span style=\"font-size:12.0pt;\">Macula and optic nerve disease</span></p>"
        },
        {
          "id": 55802,
          "text": "<p><span style=\"font-size:12.0pt;\">Cataract and glaucoma</span></p>"
        },
        {
          "id": 55803,
          "text": "<p><span style=\"font-size:12.0pt;\">Lens and cornea</span></p>"
        },
        {
          "id": 55804,
          "text": "<p><span style=\"font-size:12.0pt;\">Retina and vitreal pathologies</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What is the photostress test used to differentiate between?&nbsp;</span>&nbsp;(NEET PG 2020)</p>",
      "unique_key": "Q3082006",
      "question_audio": null,
      "question_video": null,
      "map_id": 12374661,
      "difficulty_level": "beginner",
      "subjects_id": [
        8
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A. Macula and optic nerve disease</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Photo stress test helps differentiate between diseases involving the macula and optic nerve.</span></li><li><span style=\"font-size:12.0pt;\">This test is particularly useful in early macular diseases like central serous retinopathy.</span></li><li><span style=\"font-size:12.0pt;\">One eye is covered and the patient is asked to read the smallest line on a near chart.</span></li><li><span style=\"font-size:12.0pt;\">A bright light is shone into the eye for 15 seconds, and the patient is asked to read the line again.</span></li><li><span style=\"font-size:12.0pt;\">The time taken to recover is noted, and the test is repeated with the other eye.</span></li><li><span style=\"font-size:12.0pt;\">In normal people and patients with optic nerve disease, recovery time is not affected.</span></li><li><span style=\"font-size:12.0pt;\">In patients with macular disease, recovery time is prolonged, usually more than one-third of the normal recovery time.</span></li><li><span style=\"font-size:12.0pt;\">Photoreceptor damage and delayed visual pigment regeneration process contribute to prolonged recovery time.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Cataract and glaucoma:</strong> The photostress test is not designed to differentiate between cataract and glaucoma. Cataract affects the lens, while glaucoma primarily affects the optic nerve and intraocular pressure.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Lens and cornea:</strong> The photostress test does not help in differentiating between lens and corneal pathologies. Issues with the lens (e.g., cataracts) and cornea are typically diagnosed with slit-lamp examination and other tests.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Retina and vitreal pathologies:</strong> The photostress test is not specifically used to differentiate between retinal and vitreal pathologies. Other diagnostic methods, such as ophthalmoscopy, fundus photography, and optical coherence tomography (OCT), are more appropriate for these conditions.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The photostress test is a simple and effective diagnostic tool used to differentiate between macular diseases and optic nerve diseases, based on the recovery time of vision following bright light exposure.</span></p>",
      "correct_choice_id": 55801,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "InvestigationBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 2173,
      "choices": [
        {
          "id": 8681,
          "text": "<p><span style=\"font-size:12.0pt;\">Mutation</span></p>"
        },
        {
          "id": 8682,
          "text": "<p><span style=\"font-size:12.0pt;\">Epigenetics</span></p>"
        },
        {
          "id": 8683,
          "text": "<p><span style=\"font-size:12.0pt;\">Translocation</span></p>"
        },
        {
          "id": 8684,
          "text": "<p><span style=\"font-size:12.0pt;\">Inversion</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following can alter the gene expression by methylation and acetylation but not change the gene sequence? (</span>AIIMS Nov 2017)</p>",
      "unique_key": "Q8940225",
      "question_audio": null,
      "question_video": null,
      "map_id": 12374662,
      "difficulty_level": "beginner",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Epigenetics</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Epigenetics refers to the study of changes in gene function that are heritable through cell division (mitotic and meiotic) but do not involve alterations in the DNA sequence. Epigenetic modifications can regulate gene expression by altering the accessibility of transcription factors to the DNA.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Mechanisms of Epigenetics:</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\"><strong>Histone Acetylation</strong>: The acetylation of specific lysine residues in core histones (H3 and H4) leads to an open chromatin structure, facilitating the access of transcription factors to the DNA and thereby promoting gene transcription.</span></li><li><span style=\"font-size:12.0pt;\"><strong>DNA Methylation</strong>: The addition of methyl groups to cytosine residues, particularly at CpG dinucleotides within gene promoters, leads to chromatin condensation and transcriptional repression.</span></li></ol><p><span style=\"font-size:12.0pt;\">Epigenetic modifications such as methylation and acetylation play crucial roles in regulating gene expression and can influence various biological processes, including development, differentiation, and carcinogenesis, without altering the underlying DNA sequence.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Mutation</strong>: Mutations involve changes in the DNA sequence, such as substitutions, deletions, or insertions, which can affect gene function and expression.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Translocation</strong>: This refers to the rearrangement of parts between nonhomologous chromosomes, which involves changes in the DNA sequence and can disrupt gene function.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Inversion</strong>: An inversion is a chromosomal rearrangement in which a segment of a chromosome is reversed end to end, involving changes in the DNA sequence.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><span style=\"font-size:10.5pt;\"><strong>&nbsp;</strong></span></p><p><span style=\"font-size:12.0pt;\">Epigenetics involves modifications such as methylation and acetylation that regulate gene expression without changing the DNA sequence, playing a crucial role in various biological processes and diseases.</span></p>",
      "correct_choice_id": 8682,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20876,
      "choices": [
        {
          "id": 83468,
          "text": "<p><span style=\"font-size:12pt;\">Brachial cyst</span></p>"
        },
        {
          "id": 83469,
          "text": "<p><span style=\"font-size:12pt;\">Thyroglossal cyst</span></p>"
        },
        {
          "id": 83470,
          "text": "<p><span style=\"font-size:12pt;\">Plunging ranula</span></p>"
        },
        {
          "id": 83471,
          "text": "<p><span style=\"font-size:12pt;\">Dermoid cyst</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">A 28-year-old male patient presents in surgery OPD with midline swelling in the neck. The swelling moves with deglutition and protrusion of the tongue. What is the likely diagnosis?</span>(NEET PG 2023)</p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/07/08/picture44_42lZVYr.jpg\" alt=\"\" width=\"225\" height=\"290\"></span></p>",
      "unique_key": "Q7855960",
      "question_audio": null,
      "question_video": null,
      "map_id": 12374663,
      "difficulty_level": "beginner",
      "subjects_id": [
        12
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) Thyroglossal cyst</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Pathology – Remnant of thyroglossal duct</span></li><li><span style=\"font-size:12pt;\">Most common site – midline à Subhyoid</span></li><li><span style=\"font-size:12pt;\">C/F – Presents in 2nd /3rd decade of life as midline neck swelling which moves up on tongue protrusion and on deglutition.</span></li><li><span style=\"font-size:12pt;\">Treatment - Sistrunk’s operation</span></li><li><span style=\"font-size:12pt;\">Long standing thyroglossal cyst has a risk of papillary carcinoma thyroid</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Branchial cyst:</strong> Failure of obliteration of branchial cleft. Cystic swelling (soft)- typically in a teenager. Swelling at upper 1/3rd + middle 1/3rd junction of sternocleidomastoid.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/19/666.jpg\" alt=\"\" width=\"300\" height=\"218\"></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Plunging ranula:</strong> Presents as Swelling in floor of mouth, Fluctuation present, Brilliant transillumination.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/31/picture46.jpg\" alt=\"\" width=\"300\" height=\"244\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Dermoid cyst:</strong> Caused when&nbsp;skin and skin structures become trapped during fetal development.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/31/picture1333.jpg\" alt=\"\" width=\"300\" height=\"234\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">A midline neck swelling that moves with deglutition and protrusion of the tongue is characteristic of a thyroglossal cyst, which is a remnant of the thyroglossal duct.</span></li><li><span style=\"font-size:12.0pt;\">The treatment is typically surgical removal via the Sistrunk procedure.</span></li></ul>",
      "correct_choice_id": 83469,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "ImageBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54272,
      "choices": [
        {
          "id": 216557,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">SGLT2 inhibitors</span></span></p>"
        },
        {
          "id": 216558,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Finerenone</span></span></p>"
        },
        {
          "id": 216559,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hydrochlorothiazide</span></span></p>"
        },
        {
          "id": 216560,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Angiotensin receptor blockers</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A 55-year-old patient with type 2 diabetes mellitus is being evaluated for medications to manage their condition and prevent renal complications. Which of the following drugs will not delay progression of renal disease?</span></span></span>&nbsp;(INICET MAY 2024)</p>",
      "unique_key": "Q2297921",
      "question_audio": null,
      "question_video": null,
      "map_id": 12374664,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C) Hydrochlorothiazide</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hydrochlorothiazide is a thiazide diuretic primarily used to treat hypertension and edema. It is not specifically known to delay the progression of renal disease in patients with type 2 diabetes mellitus. While it helps in managing blood pressure, it does not have the protective renal effects seen with other medications listed.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. SGLT2 inhibitors:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> These drugs, such as dapagliflozin and empagliflozin, have been shown to provide renal protection by reducing the progression of kidney disease in patients with type 2 diabetes. They work by decreasing glucose reabsorption in the kidneys, leading to osmotic diuresis and reduced glomerular hyperfiltration.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. Finerenone:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> This is a non-steroidal mineralocorticoid receptor antagonist (MRA) approved for the treatment of chronic kidney disease in type 2 diabetes. It helps to reduce albuminuria and slows the progression of renal disease.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Angiotensin receptor blockers (ARBs):</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> ARBs, such as losartan and valsartan, are well-known for their renal protective effects. They help reduce proteinuria and slow the progression of diabetic nephropathy by blocking the effects of angiotensin II on the kidneys.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hydrochlorothiazide does not delay the progression of renal disease in patients with type 2 diabetes. In contrast, SGLT2 inhibitors, finerenone, and angiotensin receptor blockers are all known to provide renal protection and slow the progression of diabetic kidney disease.</span></span></span></p>",
      "correct_choice_id": 216559,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10124,
      "choices": [
        {
          "id": 40462,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">EDTA</span></span></span></p>"
        },
        {
          "id": 40463,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Citrate</span></span></span></p>"
        },
        {
          "id": 40464,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Sodium Fluoride</span></span></span></p>"
        },
        {
          "id": 40465,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Lithium Heparin</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which anticoagulant is used for electrolyte estimation?</span></span> (AIIMS MAY 2017)</p>",
      "unique_key": "Q5067237",
      "question_audio": null,
      "question_video": null,
      "map_id": 12374665,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. D) Lithium Heparin</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Lithium Heparin&nbsp;</span></strong><span style=\"font-size:12.0pt\">is preferred for electrolyte testing because it does not interfere with the measurement of most electrolytes, such as sodium, potassium, and chloride. It is also the best anticoagulant for tests that require accurate <strong>pH</strong>, <strong>blood gases</strong>, <strong>electrolytes</strong>, and <strong>ionized calcium</strong> levels.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. EDTA:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> While EDTA is widely used for hematological examinations, it is not suitable for electrolyte estimation because it can chelate calcium and interfere with other ion measurements.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. Citrate:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Sodium citrate is primarily used for coagulation studies (e.g., PT, PTT) because it binds calcium ions to prevent clotting, but it is not ideal for electrolyte estimation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Sodium Fluoride:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Sodium fluoride is used primarily for glucose and lactate testing because it inhibits glycolysis, but it is not appropriate for electrolyte testing as it can interfere with the results.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/04/screenshot-2024-09-04-112143.png\" style=\"height:680px; width:1000px\" /></span></strong></span></span></p>",
      "correct_choice_id": 40465,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual",
        "InstrumentsBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14636,
      "choices": [
        {
          "id": 58505,
          "text": "<p><span style=\"font-size:12.0pt;\">Bilateral popliteal arteries</span></p>"
        },
        {
          "id": 58506,
          "text": "<p><span style=\"font-size:12.0pt;\">Bilateral internal iliac arteries</span></p>"
        },
        {
          "id": 58507,
          "text": "<p><span style=\"font-size:12.0pt;\">Aortoiliac bifurcation</span></p>"
        },
        {
          "id": 58508,
          "text": "<p><span style=\"font-size:12.0pt;\">Bilateral femoral arteries</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 40-year-old male patient presents with erectile dysfunction and bilateral leg pain that worsens with rest. The patient reports a history of smoking and high blood pressure. Physical examination reveals reduced sensation in both legs and weak pulses in the feet. Identify the location of the lesion?&nbsp;</span>(NEET PG 2022)</p>",
      "unique_key": "Q5657924",
      "question_audio": null,
      "question_video": null,
      "map_id": 12374666,
      "difficulty_level": "beginner",
      "subjects_id": [
        12
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C) Aortoiliac bifurcation</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Bilateral lower limb claudication, weak pulses, and erectile dysfunction are suggestive of Leriche’s syndrome.</span></li><li><span style=\"font-size:12pt;\">Leriche’s syndrome is a rare form of peripheral arterial disease caused by the obstruction or narrowing of the abdominal aorta, specifically at the aortoiliac bifurcation.</span></li><li><span style=\"font-size:12pt;\">This is the location where the abdominal aorta splits into the left and right common iliac arteries.</span></li><li><span style=\"font-size:12pt;\">Leriche syndrome (or aortoiliac occlusive disease) results from a blockage at this bifurcation.</span></li><li><span style=\"font-size:12pt;\">Patients with this condition experience claudication (pain in the buttocks and thighs), erectile dysfunction (because of reduced blood flow to the pelvis), and decreased pulses in the legs.</span></li><li><span style=\"font-size:12pt;\">Given the combination of symptoms, this location is the most plausible for the lesion in the presented case.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Bilateral popliteal arteries:&nbsp;</strong>Obstruction or narrowing of these arteries could cause pain in the calves or feet, especially after walking or exercise. It would not explain the symptoms of erectile dysfunction.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Bilateral internal iliac arteries:&nbsp;</strong>The internal iliac arteries supply various pelvic organs, including the prostate, bladder, and rectum. While occlusion of the internal iliac arteries might explain some of the pelvic symptoms like erectile dysfunction, it's not likely to cause bilateral leg pain and reduced sensation in both legs.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Bilateral femoral arteries:&nbsp;</strong>The femoral arteries supply blood to the thighs and lower legs. Obstruction in these arteries can cause pain in the thighs or calves during walking or exercise. However, this wouldn't typically result in erectile dysfunction.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Given the combination of erectile dysfunction, bilateral leg pain that worsens with rest, and the reduced pulses in the feet, the aortoiliac bifurcation (option C) is the most likely location of the lesion, consistent with Leriche syndrome.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Leriche syndrome, also known as aortoiliac occlusive disease, involves obstruction at the aortoiliac bifurcation, leading to symptoms like claudication, erectile dysfunction, and decreased lower limb pulses.</span></li></ul>",
      "correct_choice_id": 58507,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 24701,
      "choices": [
        {
          "id": 98765,
          "text": "<p><span style=\"font-size:12.0pt;\">Rest pain is seen more in the night</span></p>"
        },
        {
          "id": 98766,
          "text": "<p><span style=\"font-size:12.0pt;\">Pain in intermittent claudication comes at first step of walking.</span></p>"
        },
        {
          "id": 98767,
          "text": "<p><span style=\"font-size:12.0pt;\">Most common cause is atheroma</span></p>"
        },
        {
          "id": 98768,
          "text": "<p><span style=\"font-size:12.0pt;\">The clinical stem does not reflect the site of peripheral arterial obstruction</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the statements regarding claudication pain is incorrect? </span><span style=\"font-size:11pt;\">(</span><span style=\"font-size:12.0pt;\">INICET MAY 2023)</span></p>",
      "unique_key": "Q5699180",
      "question_audio": null,
      "question_video": null,
      "map_id": 12374667,
      "difficulty_level": "intermediate",
      "subjects_id": [
        12
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Pain in intermittent claudication comes at first step of walking.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Intermittent claudication is characterized by muscle pain (ache, cramp, numbness or sense of fatigue), classically in the calf muscle, which occurs during exercise and is relieved by a short period of rest (&lt; 5 minutes). The pain does not typically start with the first step but develops after a predictable distance of walking.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Rest pain is seen more in the night:&nbsp;</strong>True. Rest pain is a more severe symptom of peripheral artery disease (PAD). It typically indicates more advanced disease than intermittent claudication. This pain occurs when the limb is at rest, often at night due to the decreased perfusion that results from the horizontal position of the limb. It often awakens the patient from sleep and can be relieved by hanging the leg over the bed or walking.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Most common cause is atheroma:&nbsp;</strong>True. The most common cause of intermittent claudication is atherosclerosis (plaque or atheroma formation) in the peripheral arteries. This reduces blood flow to the muscles during activity, causing pain.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. The clinical stem does not reflect the site of peripheral arterial obstruction:&nbsp;</strong>True. The site of pain (e.g., calf, thigh) does not always directly correlate with the level of arterial obstruction. For instance, while calf pain is often due to femoropopliteal disease, it can also be caused by aortoiliac disease. However, the location of claudication pain can provide a clue to the level of disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The incorrect statement among the provided options is that pain in intermittent claudication occurs at the first step of walking.</span></p>",
      "correct_choice_id": 98766,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3396,
      "choices": [
        {
          "id": 13563,
          "text": "<p><span style=\"font-size:12.0pt;\">Ganciclovir resistance is due to mutation in UL97 phosphotransferase gene</span></p>"
        },
        {
          "id": 13564,
          "text": "<p><span style=\"font-size:12.0pt;\">CMV can be cultured in vitro in any mammalian cell</span></p>"
        },
        {
          "id": 13565,
          "text": "<p><span style=\"font-size:12.0pt;\">Commonest manifestation of CMV associated disease is watery diarrhea</span></p><p>&nbsp;</p>"
        },
        {
          "id": 13566,
          "text": "<p><span style=\"font-size:12.0pt;\">UL54 mutated CMV strains do not show cross resistance to Foscarnet</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Choose the correct statement regarding CMV? (INICET MAY 2018)</span></p>",
      "unique_key": "Q7107615",
      "question_audio": null,
      "question_video": null,
      "map_id": 12374668,
      "difficulty_level": "intermediate",
      "subjects_id": [
        6
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Ganciclovir resistance is due to mutation in UL97 phosphotransferase gene</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Resistance to ganciclovir&nbsp;</strong>(GCV) most commonly occurs <strong>due to mutations in the UL97 phosphotransferase gene.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Viral UL97 kinase and UL54 DNA polymerase gene mutations are well-documented mechanisms of resistance to current antivirals. The UL97 kinase normally phosphorylates serine and threonine residues of various cellular and viral proteins, and is required for efficient CMV replication. This kinase also effects the initial phosphorylation of GCV that is required for antiviral activity, and UL97 mutations that impair this phosphorylation are the preferred mechanism of GCV resistance.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>UL54 mutations can confer resistance to all current drugs</strong> and may emerge after prolonged GCV therapy to increase the level of resistance conferred by a pre-existing UL97 mutation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B:&nbsp;</strong>Human <strong>CMV replicates in vitro only in human fibroblasts</strong>, although the virus is often isolated from epithelial cells of the host.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C</strong>: CMV infection is <strong>mostly subclinical</strong>. In immunocompromised individuals, CMV can cause various manifestations, including retinitis, colitis, esophagitis, pneumonitis, and encephalitis, but watery diarrhea is not the most common manifestation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D:&nbsp;</strong>UL54 mutations can confer resistance to ganciclovir, cidofovir, and foscamet. These mutations affect the viral DNA polymerase, leading to cross-resistance to multiple antiviral drugs.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">CMV is ganciclovir resistance is due to mutation in the UL97 phosphotransferase gene. This gene is responsible for the initial phosphorylation of ganciclovir, and mutations here can prevent the drug's activation, leading to resistance. Human CMV replicates in vitro only in human fibroblasts, and UL54 mutations can confer cross-resistance to multiple antiviral drugs, including foscarnet. CMV infections are mostly subclinical, and the common manifestations in immunocompromised patients are not typically watery diarrhea.</span></p>",
      "correct_choice_id": 13563,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 43260,
      "choices": [
        {
          "id": 172707,
          "text": "<p><span style=\"font-size:12pt;\">27</span></p>"
        },
        {
          "id": 172708,
          "text": "<p><span style=\"font-size:12pt;\">36</span></p>"
        },
        {
          "id": 172709,
          "text": "<p><span style=\"font-size:12pt;\">45</span></p>"
        },
        {
          "id": 172710,
          "text": "<p><span style=\"font-size:12pt;\">53</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">Calculate the percentage of burns in a patient that presented to the&nbsp; emergency with flame burn injury covering the entire&nbsp; chest and abdomen, the entire right upper limb and full circumference of the&nbsp; right thigh.</span>(INICET NOV 2023)</p>",
      "unique_key": "Q9856799",
      "question_audio": null,
      "question_video": null,
      "map_id": 12374669,
      "difficulty_level": "intermediate",
      "subjects_id": [
        10
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B. 36</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">To calculate the percentage of body surface area affected by burns, the Rule of Nines is often used in adults. This method divides the body into sections that represent 9% (or multiples thereof) of the body surface area.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">As per the case scenario given :</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Chest and abdomen: 18%</span></li><li><span style=\"font-size:12pt;\">Right upper limb: 9%</span></li><li><span style=\"font-size:12pt;\">Right thigh: 9%</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Total = 18% (chest and abdomen) + 9% (right upper limb) + 9% (right thigh) = 36%</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">This calculation as per the case scenario and Wallace rule of 9 results in a total burned body surface area of 36%, which corresponds to option B.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Rule of Nine</strong></span></p><p>&nbsp;</p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/08/screenshot-2024-05-08-095834.JPG\" alt=\"\" width=\"500\" height=\"276\"></p>",
      "correct_choice_id": 172708,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6470,
      "choices": [
        {
          "id": 25849,
          "text": "<p><span style=\"font-size:12.0pt;\">It is a GLP- 2 analogue</span></p>"
        },
        {
          "id": 25850,
          "text": "<p><span style=\"font-size:12.0pt;\">Its half-life is 6 - 8 hours</span></p>"
        },
        {
          "id": 25851,
          "text": "<p><span style=\"font-size:12.0pt;\">It is administered orally</span></p>"
        },
        {
          "id": 25852,
          "text": "<p><span style=\"font-size:12.0pt;\">It is recommended for patients with colorectal cancer</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">True statement about teduglutide is? (NEET PG 2019)</span></p>",
      "unique_key": "Q3150068",
      "question_audio": null,
      "question_video": null,
      "map_id": 12374720,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) It is a GLP- 2 analogue</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Teduglutide is a glucagon-like peptide-2 (GLP-2) analogue. It is used to treat short bowel syndrome in adults and works by promoting the growth of the intestinal lining, thereby improving nutrient absorption.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Its half-life is 6 - 8 hours</strong>: The half-life of teduglutide is actually around 2 hours, not 6-8 hours.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. It is administered orally</strong>: Teduglutide is not administered orally; it is administered via subcutaneous injection.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. It is recommended for patients with colorectal cancer</strong>: Teduglutide is not recommended for patients with colorectal cancer. It is specifically approved for use in patients with short bowel syndrome.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Therefore, the true statement about teduglutide is that it is a GLP-2 analogue, making option A the correct answer.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Teduglutide is a GLP-2 analogue used to treat short bowel syndrome. It is administered via subcutaneous injection and has a half-life of about 2 hours. It is not recommended for patients with colorectal cancer.</span></p>",
      "correct_choice_id": 25849,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7102,
      "choices": [
        {
          "id": 28376,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Rosiglitazone</span></span></span></p>"
        },
        {
          "id": 28377,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Liraglutide</span></span></span></p>"
        },
        {
          "id": 28378,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Voglibose</span></span></span></p>"
        },
        {
          "id": 28379,
          "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Canagliflozin</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following anti-diabetic drugs is associated with the increased risk of fractures? (INICET MAY 2022)</span></span></p>",
      "unique_key": "Q4573412",
      "question_audio": null,
      "question_video": null,
      "map_id": 12374721,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A. Rosiglitazone</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Rosiglitazone, a drug belonging to the class of thiazolidinediones, has been associated with an increased risk of bone fractures. The mechanism behind this is not fully understood, but it is thought that thiazolidinediones might interfere with bone metabolism (PPAR&gamma; agonist), leading to decreased bone mineral density which can increase the risk of fractures, especially in postmenopausal women.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">B. Liraglutide</span></strong><span style=\"font-size:12.0pt\">: It is a&nbsp;GLP-1 receptor agonist used in the treatment of type 2 diabetes. There is no strong evidence linking liraglutide to an increased risk of fractures.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">C. Voglibose</span></strong><span style=\"font-size:12.0pt\">: It is an alpha-glucosidase inhibitor which delays the absorption of carbohydrates from the intestines. It has not been primarily associated with an increased risk of fractures.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">D. Canagliflozin</span></strong><span style=\"font-size:12.0pt\">: It is one of the&nbsp;SGLT2 inhibitors that works by removing glucose through the urine. While there have been some discussions about bone density changes with SGLT2 inhibitors, canagliflozin specifically has had mixed results in studies regarding fracture risk.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Glitazones like rosiglitazone and pioglitazone are associated with following adverse effects:</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hepatotoxicity</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Retention of sodium and water</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Risk of osteoporotic fractures</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">SGLT-2 inhibitors like canagliflozin is also associated with increased risk of fractures but the incidence is much lower than that with glitazones.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:16px\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/01/antidiabetic-agents-for-type-2-diabetes-mellitus-treatment.jpg\" style=\"height:1453px; width:1000px\" /></span></span></span></p>",
      "correct_choice_id": 28376,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9802,
      "choices": [
        {
          "id": 39175,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Focal segmental glomerulosclerosis (FSGS)</span></span></span></p>"
        },
        {
          "id": 39176,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Post-streptococcal glomerulonephritis (PSG)</span></span></span></p>"
        },
        {
          "id": 39177,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Good pasture syndrome</span></span></span></p>"
        },
        {
          "id": 39178,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Lupus nephritis</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A middle-aged male patient has proteinuria. Looking at the immunofluorescence image below, what is the diagnosis? (AIIMS NOV 2018)</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/12/946.jpg\" style=\"height:217px; width:500px\" /></span></span></span></p>",
      "unique_key": "Q6612801",
      "question_audio": null,
      "question_video": null,
      "map_id": 12374722,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. D) Lupus nephritis</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The given immunofluorescence staining of the kidney biopsy specimen shows positive staining for fibrinogen, IgG, IgA, IgM, C1q, C3, &lambda; chain, and k light chain. This is <strong>known as full-house effect</strong>. It is seen in lupus nephritis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Six patterns of lupus nephritis</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol style=\"list-style-type:lower-alpha\">\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Class I - Minimal lesions - deposits within the <u>mesangium p</u>ositive for IgG and C3.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Class II &ndash; Mesangial lupus nephritis - Granular <u>mesangial deposits </u>of IgG and C3; sometimes IgA and IgM are also present in the deposits.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Class III &ndash; Focal segmental lupus nephritis</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> - Subendothelial and subepithelial deposits of IgG, often with IgM or IgA and C3, are seen.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Class IV &ndash; Diffuse lupus nephritis </span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">&ndash; <strong>Most severe and most common</strong>. Deposits in the mesangium and in the <strong>subendothelial region</strong> which on immunofluorescence are positive for IgG; sometimes also for IgA or IgM, and C3.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Class V &ndash; Membranous Lupus Nephritis</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> - <strong>subendothelial</strong> deposits of immune complexes containing IgG, IgM and C3</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Class VI &ndash; Sclerosing Lupus nephritis</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> - End-stage kidney of SLE. Most glomeruli are sclerosed and hyalinised and there may be remnants of preceding lesions.</span></span></span></li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A. Focal segmental glomerulosclerosis (FSGS)</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This does not typically show a full-house pattern on immunofluorescence. FSGS is usually characterized by segmental glomerular scarring and may show focal deposits of IgM and C3.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">B. Post-streptococcal glomerulonephritis (PSG)</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This condition typically shows deposits of IgG and C3 in a &quot;starry sky&quot; pattern on immunofluorescence but does not display a full-house pattern.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">C. Goodpasture syndrome</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This typically shows linear deposits of IgG along the glomerular basement membrane, without the full-house pattern seen in lupus nephritis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The <strong>full-house effect</strong> on immunofluorescence (positive staining for IgG, IgA, IgM, C1q, C3, &lambda; chain, and &kappa; light chain) is a hallmark of <strong>lupus nephritis</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref: Robbins Pathologic basis of disease 8<sup>th</sup> edition, Pg 409-410</span></strong></span></span></p>",
      "correct_choice_id": 39178,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "DiagnosisBased",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 57182,
      "choices": [
        {
          "id": 228117,
          "text": "<p><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Progressive supranuclear palsy</span></span></p>"
        },
        {
          "id": 228118,
          "text": "<p><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Multiple system atrophy</span></span></p>"
        },
        {
          "id": 228119,
          "text": "<p><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Parkinson&rsquo;s disease</span></span></p>"
        },
        {
          "id": 228120,
          "text": "<p><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Amyotrophic lateral sclerosis (ALS)</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">A 63-year-old man presents to the neurology clinic with complaints of difficulty walking, muscle stiffness, and a tremor in his right hand that worsens when at rest. His wife reports that he has become slower in his movements over the past year and occasionally experiences a shuffling gait. Neurological examination reveals bradykinesia, cogwheel rigidity, and a resting tremor in both hands. An MRI of the brain shows atrophy of the substantia nigra, which is marked in the diagram below. Which of the following diseases is most closely associated with degeneration of this structure?</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/14/picture1.jpg\" style=\"height:200px; width:300px\" /></span></span></span></p>",
      "unique_key": "Q9524791",
      "question_audio": null,
      "question_video": null,
      "map_id": 12374743,
      "difficulty_level": "beginner",
      "subjects_id": [
        2
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Correct Answer: C. Parkinson&rsquo;s disease</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Parkinson&rsquo;s disease is primarily associated with the degeneration of the substantia nigra, a structure in the midbrain responsible for producing dopamine, which is essential for coordinating smooth and purposeful movements. The loss of dopamine-producing neurons leads to the characteristic motor symptoms of Parkinson&rsquo;s disease, including bradykinesia, muscle rigidity, and resting tremors. The substantia nigra appears pigmented due to neuromelanin, but in Parkinson&rsquo;s disease, this pigmentation is reduced due to neuronal loss. The disease progresses gradually and often leads to significant motor impairment and a distinct shuffling gait.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Option A. Progressive supranuclear palsy</span></strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">: This is a neurodegenerative disorder that primarily affects the brainstem and basal ganglia, leading to postural instability, vertical gaze palsy, and bradykinesia. While it shares some symptoms with Parkinson&rsquo;s disease, it does not specifically target the substantia nigra as the main site of degeneration.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Option B. Multiple system atrophy</span></strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">: This neurodegenerative disorder affects multiple areas of the brain, including the basal ganglia, cerebellum, and autonomic nervous system, but does not specifically target the substantia nigra as the primary site of degeneration as seen in Parkinson&rsquo;s disease.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Option D. Amyotrophic lateral sclerosis (ALS)</span></strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">: ALS primarily affects the motor neurons in the brain and spinal cord, leading to progressive muscle weakness, atrophy, and spasticity. It does not involve the substantia nigra, and patients do not typically present with parkinsonian features such as tremors and rigidity.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Parkinson&rsquo;s disease is characterized by the degeneration of the substantia nigra, resulting in dopamine deficiency that manifests as bradykinesia, muscle rigidity, and resting tremors. The hallmark pathological finding is reduced neuromelanin pigmentation in the substantia nigra due to neuronal loss.</span></span></span></p>",
      "correct_choice_id": 228119,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14394,
      "choices": [
        {
          "id": 57537,
          "text": "<p><span style=\"font-size:12.0pt;\">Gall bladder thickness &gt;3 mm on USG</span></p>"
        },
        {
          "id": 57538,
          "text": "<p><span style=\"font-size:12.0pt;\">Murphy's sign positive</span></p>"
        },
        {
          "id": 57539,
          "text": "<p><span style=\"font-size:12.0pt;\">Leukocytosis</span></p>"
        },
        {
          "id": 57540,
          "text": "<p><span style=\"font-size:12.0pt;\">Preferential visualization of gall bladder in HIDA scan</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">50-year-old obese female presents to the emergency department with severe right upper quadrant pain, fever, and nausea. The physician suspects acute cholecystitis and orders imaging studies to confirm the diagnosis. Which of the following statements is not true about acute cholecystitis? (INICET NOV 2022)</span></p>",
      "unique_key": "Q9149344",
      "question_audio": null,
      "question_video": null,
      "map_id": 12374744,
      "difficulty_level": "beginner",
      "subjects_id": [
        12
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Preferential visualization of gall bladder in HIDA scan.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This statement is not true. In a Hepatobiliary Iminodiacetic Acid (HIDA) scan, the gallbladder is not preferentially visualized in acute cholecystitis. Instead, one of the hallmark findings in acute cholecystitis on a HIDA scan is non-visualization of the gallbladder due to inflammation and obstruction of the cystic duct.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Gall bladder thickness &gt;3 mm on USG</strong>: This statement is true and is a common finding in acute cholecystitis. On ultrasound (USG), a thickened gallbladder wall, typically greater than 3 mm, is indicative of inflammation and is a characteristic feature of acute cholecystitis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>B. Murphy's sign positive</strong>: This statement is true. Murphy's sign is a clinical maneuver used to assess for acute cholecystitis. It involves palpation of the right upper quadrant during inspiration, and if the patient experiences pain or stops breathing due to pain during this maneuver, it is considered a positive Murphy's sign, suggesting inflammation of the gallbladder.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>C.</strong> <strong>Leukocytosis</strong>: This statement is true. Acute cholecystitis is associated with an inflammatory response, leading to an elevation in white blood cell count, which is known as leukocytosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Acute cholecystitis is a common condition characterized by inflammation of the gallbladder, typically due to the presence of gallstones obstructing the cystic duct. Clinical features of acute cholecystitis include right upper quadrant pain, fever, and leukocytosis. A positive Murphy's sign is right upper quadrant tenderness on palpation. On ultrasound imaging, gall bladder thickness &gt;3 mm is a common finding in acute cholecystitis. The HIDA scan is a diagnostic tool for acute cholecystitis, showing non-visualization of the gall bladder 3 hours after radioisotope administration. Preferential visualization of the gall bladder on a HIDA scan is not a feature of acute cholecystitis. It is important to diagnose and treat acute cholecystitis promptly to prevent complications such as gallbladder perforation or gangrene.</span></p>",
      "correct_choice_id": 57540,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 57183,
      "choices": [
        {
          "id": 228121,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Testosterone </span></span></span></p>"
        },
        {
          "id": 228122,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Estrogen </span></span></span></p>"
        },
        {
          "id": 228123,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Progesterone </span></span></span></p>"
        },
        {
          "id": 228124,
          "text": "<p><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">DHEA</span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which hormone is most affected by changes in sex hormone binding globulin (SHBG) levels?&nbsp; (AIIMS NOV 2016)</span></span></p>",
      "unique_key": "Q7789602",
      "question_audio": null,
      "question_video": null,
      "map_id": 12374745,
      "difficulty_level": "intermediate",
      "subjects_id": [
        2
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Answer: A. Testosterone</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Explanation</span></strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Testosterone levels are significantly influenced by changes in sex hormone binding globulin (SHBG). SHBG has a higher affinity for testosterone compared to estrogen, making it more susceptible to fluctuations in SHBG levels. When SHBG levels increase, more testosterone is bound and less is available in its free, bioactive form. Conversely, when SHBG levels decrease, more testosterone is available in its free form. This binding dynamic is crucial because only free testosterone can activate androgen receptors and exert biological effects.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Other options:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Option B (Estrogen)</span></strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"> is incorrect because, although SHBG also binds to estrogen, its affinity for testosterone is higher, thus affecting testosterone levels more profoundly.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Option C (Progesterone)</span></strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"> is incorrect as SHBG has a lower affinity for progesterone than for testosterone.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Option D (DHEA)</span></strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"> is incorrect because DHEA (dehydroepiandrosterone) is primarily bound by albumin rather than SHBG, and thus is less influenced by changes in SHBG levels compared to testosterone.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">The level of free, biologically active testosterone in the blood is more significantly affected by changes in SHBG levels compared to other sex hormones due to its higher binding affinity.</span></span></span></p>",
      "correct_choice_id": 228121,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10438,
      "choices": [
        {
          "id": 41718,
          "text": "<p><span style=\"font-size:12.0pt;\">Idiopathic acquired aplastic anemia</span></p>"
        },
        {
          "id": 41719,
          "text": "<p><span style=\"font-size:12.0pt;\">Paroxysmal nocturnal hemoglobinuria</span></p>"
        },
        {
          "id": 41720,
          "text": "<p><span style=\"font-size:12.0pt;\">Myelodysplastic syndrome</span></p>"
        },
        {
          "id": 41721,
          "text": "<p><span style=\"font-size:12.0pt;\">Tuberculosis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">An 18-year-old male presented to the outpatient department with gum bleeding and fever for the past 2 months. General examination showed pallor and the systemic examination was unremarkable. Laboratory examination revealed Hb level- 3 gm/dI, TLC-1500/microL, platelet count - 15000/microL. Peripheral smear shows macrocytes and the reticulocyte count is 0.5. Bone marrow examination revealed fatty streaks and absent megakaryocytes but no immature cells. What is the likely diagnosis? (Hb- Hemoglobin, TLC- Total leucocyte count)? (NEET PG 2021)</span></p>",
      "unique_key": "Q5158214",
      "question_audio": null,
      "question_video": null,
      "map_id": 12374916,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Idiopathic acquired aplastic anemia</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The given clinical scenario showing a young male with gum bleeding, fever, pancytopenia, and a low reticulocyte count with bone marrow showing fatty streaks and no immature cells is suggestive of idiopathic acquired aplastic anemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Key Diagnostic Features of Aplastic Anemia:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Pancytopenia (low Hb, WBC, and platelets)</span></li><li><span style=\"font-size:12.0pt;\">Hypocellular (fatty) bone marrow</span></li><li><span style=\"font-size:12.0pt;\">No immature/blast cells</span></li><li><span style=\"font-size:12.0pt;\">Low reticulocyte count (indicates bone marrow failure)</span></li><li><span style=\"font-size:12.0pt;\">Macrocytes due to ineffective hematopoiesis</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Paroxysmal Nocturnal Hemoglobinuria (PNH):&nbsp;</strong>PNH is characterized by hemolysis, hemoglobinuria (especially in the morning), and thrombosis. The presentation of pancytopenia with bone marrow aplasia is more suggestive of idiopathic acquired aplastic anemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Myelodysplastic Syndrome (MDS):&nbsp;</strong>MDS are a diverse group of hematopoietic clonal stem cell disorders characterized by abnormal development of various marrow elements (i.e., dysmyelopoiesis), cytopenias, cellular marrow, and ineffective blood cell formation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Tuberculosis:&nbsp;</strong>Tuberculosis can cause pancytopenia if the bone marrow is involved, but the bone marrow would show granulomas rather than the fatty streaks and absence of immature cells seen in aplastic anemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Causes of pancytopenia</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">I. Aplastic anemia</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">II. Pancytopenia with normal or increased marrow cellularity</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">e.g.</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">&nbsp;Myelodysplastic syndromes</span></li><li><span style=\"font-size:12.0pt;\">Hypersplenism</span></li><li><span style=\"font-size:12.0pt;\">&nbsp;Megaloblastic anemia</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">III. Paroxysmal nocturnal hemoglobinuria</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">IV. Bone marrow infiltrations</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">e.g:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">Hematologic malignancies (leukemias, lymphomas, myeloma)</span></li><li><span style=\"font-size:12.0pt;\">Non-hematologic metastatic malignancies</span></li><li><span style=\"font-size:12.0pt;\">Storage diseases</span></li><li><span style=\"font-size:12.0pt;\">Osteopetrosis</span></li><li><span style=\"font-size:12.0pt;\">Myelofibrosis</span></li></ol>",
      "correct_choice_id": 41718,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3885,
      "choices": [
        {
          "id": 15519,
          "text": "<p>A</p>"
        },
        {
          "id": 15520,
          "text": "<p>B</p>"
        },
        {
          "id": 15521,
          "text": "<p>C</p>"
        },
        {
          "id": 15522,
          "text": "<p>D</p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A stool sample is collected. The specimen is processed for examination and is labeled at different levels as A, B, C, and D. Identify the level at which parasitic ova will be seen when viewed under a microscope? (INICET MAY 2021)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/30/1.jpg\" alt=\"\" width=\"300\" height=\"390\"></span></p>",
      "unique_key": "Q1717927",
      "question_audio": null,
      "question_video": null,
      "map_id": 12375017,
      "difficulty_level": "intermediate",
      "subjects_id": [
        6
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) D</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The above image shows formal ether sedimentation technique.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Sedimentation techniques use solutions of lower specific gravity than the parasitic organisms, thus concentrating the latter in the sediment. It takes advantage of the high specific gravity of protozoan cysts and helminth eggs compared to water. Their natural tendency to settle out in aqueous solutions can be accelerated by light centrifugation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Formalin fixes the eggs, larvae, oocysts, and spores, so that they are no longer infectious, as well as preserves their morphology. Fecal debris is extracted into the ethyl acetate phase of the solution. Parasitic elements are sedimented at the bottom.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. A:</strong> This level contains ether, which is used to extract fecal debris and is found at the top of the tube after centrifugation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. B:</strong> This level contains the plug of debris, which is a layer of waste material that is separated from the parasitic elements and sits below the ether layer.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. C:</strong> This level contains formalin, which fixes and preserves the morphology of the parasitic elements. The formalin layer sits above the sediment but below the plug of debris.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In the formal ether sedimentation technique, parasitic ova, cysts, and larvae will be concentrated in the sediment at the bottom of the tube, labeled as level D. This sediment is where parasitic elements are found and examined under a microscope.</span></p>",
      "correct_choice_id": 15522,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "ImageBased",
        "INICET",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11076,
      "choices": [
        {
          "id": 44270,
          "text": "<p><span style=\"font-size:18px;\">Prospective Cohort</span></p>"
        },
        {
          "id": 44271,
          "text": "<p><span style=\"font-size:18px;\">Ambispective Cohort</span></p>"
        },
        {
          "id": 44272,
          "text": "<p><span style=\"font-size:12.0pt;\">Case control</span></p>"
        },
        {
          "id": 44273,
          "text": "<p><span style=\"font-size:12.0pt;\">Cross sectional</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:18px;\"><strong>You are participating in a research discussion about the best approach to study the circadian changes in the fat content of expressed breast milk among mothers of preterm babies. The primary aim is to observe the variations over time and establish a temporal relationship. Which of the following study designs would be most suitable to achieve this objective? </strong><i><strong>[AIIMS MAY 2019]</strong></i></span></p>",
      "unique_key": "Q9840192",
      "question_audio": null,
      "question_video": null,
      "map_id": 12375018,
      "difficulty_level": "beginner",
      "subjects_id": [
        7
      ],
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (a) Prospective Cohort</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">The study design of choice for the given scenario is a prospective study.</span></li><li><span style=\"font-size:18px;\">In the given situation, the study cohort would comprise of mothers with preterm infants, whereas the control cohort would include mothers with full-term babies.</span></li><li><span style=\"font-size:18px;\">To investigate the diurnal fluctuations in the fat composition of expressed breast milk, samples of breast milk would be collected at designated time points each day.</span></li><li><span style=\"font-size:18px;\">These samples would be monitored over the course of multiple days and subjected to analysis. This research constitutes a prospective study.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option B</strong>. <strong>Ambispective Cohort:</strong> An Ambispective cohort includes both retrospective and prospective cohort study. This case scenario will not fit in retrospective study</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option C. Case control:</strong> Case-control study is also a retrospective study.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option D. Cross sectional:</strong> Cross-sectional study is used to figure out the prevalence of a disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">A prospective cohort study is the optimal design for research that needs to observe how a variable changes over time and establish a chronological sequence of events or effects. This method will allow for the systematic collection of breast milk samples at various times to analyze changes in fat content relative to the time of day in a defined sample of mothers with preterm infants.</span></li></ul>",
      "correct_choice_id": 44270,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11176,
      "choices": [
        {
          "id": 44670,
          "text": "<p><span style=\"font-size:18px;\">Stability</span></p>"
        },
        {
          "id": 44671,
          "text": "<p><span style=\"font-size:18px;\">Objectivity</span></p>"
        },
        {
          "id": 44672,
          "text": "<p><span style=\"font-size:18px;\">Generalizability</span></p>"
        },
        {
          "id": 44673,
          "text": "<p><span style=\"font-size:18px;\">Repeatability</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:18px;\"><strong>You are a public health researcher evaluating a new screening test for early detection of a specific disease in a community. Your team successfully conducted a pilot study in a small group. Before planning a large-scale implementation, you wish to ensure that the findings from your pilot study can be applied to larger, diverse groups of individuals outside your initial sample. This ability to extrapolate the findings in the broader population, i.e. the external validity of a screening test is related to which of the following options?&nbsp;</strong><i><strong>[INICET NOV 2021]</strong></i></span></p>",
      "unique_key": "Q7273815",
      "question_audio": null,
      "question_video": null,
      "map_id": 12375019,
      "difficulty_level": "intermediate",
      "subjects_id": [
        7
      ],
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (c) Generalizability</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">Generalizability refers to the extent to which the findings from a study or pilot test can be applied to a broader population.</span></li><li><span style=\"font-size:18px;\">It is a measure of the external validity of a study.</span></li><li><span style=\"font-size:18px;\">Ensuring that the results of a pilot study can be extrapolated to larger, diverse groups outside the initial sample is crucial for the success of large-scale implementations.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option A. Stability:</strong> Refers to the consistency of test results over time, ensuring that repeated measurements yield the same results under unchanged conditions. While important, it does not address how findings apply to different populations.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option B. Objectivity:</strong> Ensures that test results are unbiased and not influenced by the person administering the test. While critical for reliable results, it does not relate to applying findings to a broader population.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option D. Repeatability:</strong> Refers to the consistency of the test results when repeated under identical conditions. This is crucial for reliability but does not address the applicability of the results to different populations.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective</strong>:</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">External validity of a screening test is related to generalizability.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Validity refers to what extent the test measures which it purports to measure (adequacy of measurement).</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Types of Validity</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/28/screenshot-2023-10-28-131034.jpg\" alt=\"\" width=\"800\" height=\"346\"></strong></span></p>",
      "correct_choice_id": 44672,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6689,
      "choices": [
        {
          "id": 26725,
          "text": "<p><span style=\"font-size:12.0pt;\">Observe the patient for 2 hours post meal</span></p>"
        },
        {
          "id": 26726,
          "text": "<p><span style=\"font-size:12.0pt;\">Ask the psychiatrist to prescribe anti-anxiety medication</span></p>"
        },
        {
          "id": 26727,
          "text": "<p><span style=\"font-size:12.0pt;\">Increase the calories from 1500 to 2000 in her diet</span></p>"
        },
        {
          "id": 26728,
          "text": "<p><span style=\"font-size:12.0pt;\">Increase water intake</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A patient of anorexia nervosa was eating all her meals according to the prescribed diet chart but there is no change in her weight after 1 week. Which of the following needs to be done? (</span>AIIMS Nov 2019)</p>",
      "unique_key": "Q2550231",
      "question_audio": null,
      "question_video": null,
      "map_id": 12375020,
      "difficulty_level": "beginner",
      "subjects_id": [
        16
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Observe the patient for 2 hours post meal</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">A lack of weight gain in an anorexia nervosa patient adhering to a diet can suggest surreptitious purging behaviors:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Observe the patient for 2 hours post meal: This helps in ensuring the patient isn't purging post-meal.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Anti-anxiety medication: </strong>Anxiety is common in anorexia but doesn't directly address potential purging.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Increase calories: </strong>Confirm proper consumption and retention before adjusting calories.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Increase water intake:</strong> This won't address the primary concern and may introduce other issues.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"color:#374151;font-size:12.0pt;\">In patients with anorexia nervosa who are not gaining weight despite adherence to a meal plan, it's important to first rule out surreptitious purging behaviors. Observing the patient post-meal can help ensure that they are not engaging in behaviors like vomiting or excessive exercise after eating.</span></p><p>&nbsp;</p><p><span style=\"color:#374151;font-size:12.0pt;\"><strong>Reference: Shorter Oxford Textbook of Psychiatry, 7th edition, Page No 320.</strong></span></p>",
      "correct_choice_id": 26725,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 57184,
      "choices": [
        {
          "id": 228125,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Lateral pons</span></span></span></p>"
        },
        {
          "id": 228126,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Lateral medulla</span></span></span></p>"
        },
        {
          "id": 228127,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Cerebellum</span></span></span></p>"
        },
        {
          "id": 228128,
          "text": "<p><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Thalamus</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">A 55-year-old man presents to the emergency department with sudden onset of dizziness, difficulty swallowing, and slurred speech. He also reports numbness on the right side of his face and difficulty feeling hot or cold on the left side of his body. On examination, he has ipsilateral ptosis, miosis, and anhidrosis consistent with Horner&#39;s syndrome on the right side. There is loss of pain and temperature sensation on the right side of the face and on the left side of the body. He also has gait ataxia and difficulty with coordination. Which area is most likely affected by the lesion?</span></span></span></p>",
      "unique_key": "Q8402536",
      "question_audio": null,
      "question_video": null,
      "map_id": 12375021,
      "difficulty_level": "intermediate",
      "subjects_id": [
        2
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Correct Answer: B. Lateral medulla</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">The patient&#39;s symptoms are consistent with Lateral Medullary Syndrome, also known as Wallenberg syndrome. This syndrome is typically caused by an occlusion of the vertebral artery or the posterior inferior cerebellar artery (PICA), leading to damage in the lateral medulla. The involvement of the trigeminal nerve nucleus causes ipsilateral loss of pain and temperature sensation in the face, while damage to cranial nerves IX, X, and XI results in dysphagia and dysarthria. The sympathetic chain involvement leads to Horner&#39;s syndrome, and the inferior cerebellar peduncle damage results in gait ataxia and vertigo.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Option A. Lateral pons</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Lesions in the lateral pons often present with facial weakness, loss of sensation, and hearing deficits due to involvement of the facial, trigeminal, and auditory nerves. However, it does not typically present with the combination of ipsilateral Horner&#39;s syndrome and contralateral body symptoms seen in lateral medullary syndrome.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Option C. Cerebellum</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Cerebellar lesions primarily cause coordination and balance issues, such as ataxia and vertigo. However, they do not produce the specific sensory deficits or cranial nerve abnormalities observed in this case, particularly the crossed pattern of symptoms characteristic of lateral medullary syndrome.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Option D. Thalamus</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Thalamic lesions can result in sensory deficits involving the entire body on the contralateral side due to its role in sensory relay. However, thalamic strokes do not present with the cranial nerve symptoms, Horner&rsquo;s syndrome, or the specific crossed sensory findings characteristic of lateral medullary syndrome.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Lateral medullary syndrome, most commonly caused by vertebral artery or PICA occlusion, presents with a combination of ipsilateral facial sensory loss, Horner&rsquo;s syndrome, contralateral body sensory loss, and cerebellar symptoms. Recognizing this distinct pattern helps localize the lesion to the lateral medulla and differentiates it from other brainstem and cerebellar syndromes.</span></span></span></p>",
      "correct_choice_id": 228126,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 2540,
      "choices": [
        {
          "id": 10145,
          "text": "<p><span style=\"font-size:12.0pt;\">Hybridization, Annealing, Elongation, Denaturation</span></p>"
        },
        {
          "id": 10146,
          "text": "<p><span style=\"font-size:12.0pt;\">Elongation, Denaturation, Hybridization, Annealing</span></p>"
        },
        {
          "id": 10147,
          "text": "<p><span style=\"font-size:12.0pt;\">Denaturation, Annealing, Extension</span></p>"
        },
        {
          "id": 10148,
          "text": "<p><span style=\"font-size:12.0pt;\">Annealing, Extension, Denaturation</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The correct order of steps in Polymerase Chain Reaction (PCR) is: (</span>INICET Nov 2020)</p>",
      "unique_key": "Q5704278",
      "question_audio": null,
      "question_video": null,
      "map_id": 12375042,
      "difficulty_level": "beginner",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Denaturation, Annealing, Extension</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Polymerase Chain Reaction (PCR) is a widely used method to amplify specific DNA segments. The process involves three main steps that are repeated in cycles, resulting in the exponential amplification of the target DNA sequence.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Steps of PCR:</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/07/06/whatsapp-image-2023-06-12-at-190121011089.jpg\" alt=\"\" width=\"700\" height=\"536\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The steps of 1, 2 and 3 are repeated results in the exponential amplification of DNA segments of defined length. <strong>In each cycle, the DNA strands are doubled. Thus 20 cycles provide for 1 million times amplifications.</strong> These cycles are generally repeated by automated instrument, called <strong>Thermal cycler</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>After the amplification procedure, DNA hybridization technique or Southern blot analysis with a suitable probe, shows the presence of the DNA in the sample tissue.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><span style=\"font-size:10.5pt;\"><strong>&nbsp;</strong></span></p><p><span style=\"font-size:12.0pt;\">The correct order of steps in Polymerase Chain Reaction (PCR) is Denaturation, Annealing, and Extension. These steps are repeated in cycles to exponentially amplify the target DNA segment.</span></p>",
      "correct_choice_id": 10147,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10411,
      "choices": [
        {
          "id": 41610,
          "text": "<p><span style=\"font-size:12.0pt;\">Autosomal dominant</span></p>"
        },
        {
          "id": 41611,
          "text": "<p><span style=\"font-size:12.0pt;\">Autosomal recessive</span></p>"
        },
        {
          "id": 41612,
          "text": "<p><span style=\"font-size:12.0pt;\">X-linked</span></p>"
        },
        {
          "id": 41613,
          "text": "<p><span style=\"font-size:12.0pt;\">Mitochondrial</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 6-foot 5-inch man undergoing a routine physical examination was found to have an early diastolic murmur. His family pedigree chart is given below. Identify the mode of inheritance of this condition: (NEET PG 2020)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/54_pUfVzzu.jpg\" alt=\"\" width=\"400\" height=\"211\"></span></p>",
      "unique_key": "Q9986418",
      "question_audio": null,
      "question_video": null,
      "map_id": 12375043,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Autosomal dominant</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Notice that the disease is present in all 3 generations. It is being transmitted with equal frequency from affected father to his daughters and son. So, it is autosomal dominant mode of inheritance.&nbsp; The patient's height and the presence of early diastolic murmur in the given clinical scenario are suggestive of Marfan syndrome</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Marfan syndrome is a genetic disorder that affects connective tissue, including the skeleton, cardiovascular system, and eyes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Important features of Marfan syndrome:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Tall stature with disproportionately long limbs and fingers (arachnodactyly)</span></li><li><span style=\"font-size:12.0pt;\">Aortic root dilation, which can lead to aortic aneurysm and dissection</span></li><li><span style=\"font-size:12.0pt;\">Mitral valve prolapses</span></li><li><span style=\"font-size:12.0pt;\">Lens dislocation, which can cause visual impairment or blindness</span></li><li><span style=\"font-size:12.0pt;\">Skeletal abnormalities, such as scoliosis and chest deformities</span></li><li><span style=\"font-size:12.0pt;\">Stretch marks (striae) on the skin that are not related to weight gain or loss</span></li><li><span style=\"font-size:12.0pt;\">Joint hypermobility</span></li><li><span style=\"font-size:12.0pt;\">Autosomal dominant inheritance</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/55.jpg\" alt=\"\" width=\"600\" height=\"574\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The diagnosis of Marfan syndrome is made based on clinical features and genetic testing. Treatment typically involves management of cardiovascular complications, such as regular monitoring of the aorta and prophylactic aortic surgery, if necessary, as well as management of other symptoms such as lens dislocation and skeletal abnormalities.</span></p>",
      "correct_choice_id": 41610,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "ImageBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11738,
      "choices": [
        {
          "id": 46918,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Carbimazole</span></span></span></span></p>"
        },
        {
          "id": 46919,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Methylthiouracil</span></span></span></span></p>"
        },
        {
          "id": 46920,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Levothyroxine</span></span></span></span></p>"
        },
        {
          "id": 46921,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hydrouracil</span></span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A woman with Grave&#39;s disease was taking antithyroid medication throughout her pregnancy. The baby was born with aplasia cutis congenita. Which drug could have caused this condition? (INICET NOV 2020)</span></span></p>",
      "unique_key": "Q2125201",
      "question_audio": null,
      "question_video": null,
      "map_id": 12375044,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A)&nbsp;</span></span></strong><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Carbimazole</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Carbimazole is a medication used to treat hyperthyroidism and is known to cause teratogenic effects if used during pregnancy. It can lead to a rare congenital condition called aplasia cutis congenita, where the baby is born with localized areas of missing skin. The use of carbimazole, especially during the first trimester of pregnancy, is linked with this embryopathy, which highlights the importance of careful medication selection in pregnant women with thyroid disorders.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Methylthiouracil:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Although it is an antithyroid drug, it is less commonly used and not specifically associated with aplasia cutis congenita.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Levothyroxine:</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This is a thyroid hormone replacement and is used to treat hypothyroidism, not associated with congenital defects.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Hydrouracil:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This option appears to be a distractor as no such common drug name exists that is relevant in this context.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">MMZ, Carbimazole associated with embryonopathy in first trimester</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Graves in Pregnancy:</span></span></span></span></p>\r\n\r\n<p style=\"margin-left:48px\">&nbsp;</p>\r\n\r\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&lt;16 weeks: PTU (MM teratogenic)</span></span></span></span></p>\r\n\r\n<p style=\"margin-left:48px\">&nbsp;</p>\r\n\r\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&gt;16 weeks: MMI (PTU hepatotoxicity)</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lactation: MMI (RAIA avoided 4-6 weeks after cessation of breastfeeding as RAI is concentrated in breast tissue)</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Reference - Harrison 21/Hyperthyroidism/Graves/Chap 384</span></span></strong></span></span></p>",
      "correct_choice_id": 46918,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 57185,
      "choices": [
        {
          "id": 228129,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Fever &gt; 38.3&deg;C (101&deg;F) on multiple occasions</span></span></span></p>"
        },
        {
          "id": 228130,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Duration of fever for more than 3 weeks</span></span></span></p>"
        },
        {
          "id": 228131,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Immunocompromised state</span></span></span></p>"
        },
        {
          "id": 228132,
          "text": "<p><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Uncertain diagnosis after thorough evaluation</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">A 55-year-old man presents with intermittent fever. Despite multiple evaluations, including detailed history, physical examinations, and routine laboratory tests, no clear diagnosis has been established. Which of the following criteria is not included in the definition of Pyrexia of Unknown Origin (PUO)?</span></span></span></p>",
      "unique_key": "Q5539386",
      "question_audio": null,
      "question_video": null,
      "map_id": 12375085,
      "difficulty_level": "difficult",
      "subjects_id": [
        2
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Correct Answer: D) Uncertain diagnosis after thorough evaluation</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Explanation</span></strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">The definition of Pyrexia of Unknown Origin (PUO) includes fever greater than 38.3&deg;C (101&deg;F) occurring on at least two occasions, persisting for more than three weeks, and occurring in patients who are not immunocompromised. The diagnosis requires that a comprehensive history, physical examination, and routine investigations do not establish a cause. While &quot;uncertain diagnosis after thorough evaluation&quot; describes the clinical challenge, it is not explicitly listed as part of the criteria, but rather is a consequence of the failure to identify the cause through initial investigations.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Option A) Fever &gt; 38.3&deg;C (101&deg;F) on multiple occasions</span></strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">: This is an essential component of PUO, helping to confirm the presence of persistent fever that warrants further investigation beyond common febrile illnesses.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Option B) Duration of fever for more than 3 weeks</span></strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">: This criterion distinguishes PUO from short-term febrile illnesses, emphasizing the need for an extended investigation when a fever persists without a clear cause.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Option C) Immunocompromised state</span></strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">: Immunocompromised individuals are specifically excluded from the PUO definition due to their unique diagnostic considerations and increased susceptibility to infections, which require a separate approach.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">The definition of Pyrexia of Unknown Origin (PUO) requires persistent fever over 38.3&deg;C (101&deg;F) lasting longer than three weeks in non-immunocompromised patients, where no clear cause is identified after standard evaluation. Recognizing these specific criteria helps differentiate PUO from other febrile conditions and guide further investigation.</span></span></span></p>",
      "correct_choice_id": 228132,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}